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Abstract 
 
Female pelvic organ prolapse is a common problem, which can be debilitating and 
life altering. From a pathophysiological point of view, pelvic organ prolapse can be 
considered as the herniation of pelvic organs through the levator hiatus, the largest 
potential hernia portal in the human body, into the vaginal canal. This condition 
commonly affects parous women. In the Australian population, a women’s lifetime 
risk of requiring surgical treatment for prolapse is in the order of 19%, with a 
recurrence rate as high as 40 – 60% in the anterior compartment. It appears to be the 
most challenging compartment to successfully support. Given the high surgical failure 
rate, one of the main tasks for clinicians is to improve surgical treatment. This thesis 
is aimed at identifying methods of improving our surgical outcomes, utilising 
translabial ultrasound as the principal study method.     
 
Due to the unacceptably high rates of prolapse recurrence, mesh augmentation was 
introduced as part of surgical treatment in 2003 – 2004 to Australia, in the hopes of 
improving treatment success. Despite limited data on safety and efficacy, there was a 
rapid and widespread adoption of mesh kits; however, the impact of this injudicious 
use of foreign material did not become apparent until recent years. Whilst in a 
retrospective analysis anterior mesh proved to have a lower recurrence rate 
compared to native tissue repair, it became evident that anterior anchored mesh, 
such as the Perigee™ (American Medical Systems, Minnetonka, USA) was of 
maximum benefit only in women who had sustained pelvic floor muscle trauma 
secondary to vaginal delivery. This form of trauma, termed ‘levator avulsion’, has 
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been shown to be a risk factor for prolapse development and prolapse recurrence. In 
particular, recurrence seems to affect primarily the anterior and apical compartments.  
 
Over the years, there was also increasing emphasis on the importance of apical 
support especially when performing a repair of the anterior compartment. As such, 
mesh kit systems with apical anchoring such as the Anterior Elevate™ (American 
Medical Systems, Minnetonka, USA) were introduced approximately eight years ago. 
However, in a retrospective analysis of Anterior Elevate™, which utilises anchors into 
the sacrospinous ligament, it was found to be inferior in anatomical outcomes 
compared to the Perigee™, a transobturator anchoring mesh fixation device. Whilst 
conceptually, it would make sense to provide apical anchoring, the optimal method of 
anchoring remains unproven. The findings from this study, where the Anterior 
Elevate™ was inferior to the Perigee™ may plausibly be explained by inferior 
mechanical integrity or poorer load-bearing capability of the self-fixating anchors in 
the Anterior Elevate.  
 
In another attempt to evaluate the importance of apical support, a surgical audit was 
conducted on laparoscopic sacrocolpopexy. Sacrocolpopexy has been recognised as 
the gold-standard surgical treatment for apical prolapse, which involves the 
placement of a piece of mesh from the vaginal vault to the anterior longitudinal 
ligament over the sacral promontory. Despite being a robust procedure, a surgical 
audit assessing the outcome of this treatment found that although the apex was well 
supported, there was still a very high rate of anterior compartment prolapse 
recurrence of above eighty percent. The results suggest that despite successfully 
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supporting the apex, it is important to also be providing support in the mid-vaginal 
level in order to achieve successful anatomical outcomes for cystocele repair.  
 
Regardless of anchoring methods, mesh repair does not seem to be able to 
completely compensate for the effect of levator avulsion. Furthermore, it has been 
shown that transvaginal mesh augmentation did not confer additional benefit in 
women with excessive levator hiatal area ballooning, i.e. an abnormally distensible 
hiatus, which on its own is a risk factor for prolapse recurrence. The ongoing 
disenchantment with surgical outcomes led to the development of a novel surgical 
technique designed to reduce the size of the hernia portal, the levator hiatal area. 
The ‘Puborectalis sling’ procedure involves the placement of a strip of polypropylene 
mesh lateral to the levator ani muscle, i.e., in the infralevator space of the buttocks, 
with the aim of restricting hiatal enlargement. The procedure is based on the 
hypothesis ‘The smaller the hernia portal, the less likely it is for the pelvic organs to 
descend through it’. A phase II clinical observational surgical trial was performed as a 
pilot study including over a hundred and ten women requiring prolapse surgery.  A 
mean reduction of the levator hiatal area by 12cm2 was achieved and sustained for 
over two years, achieving ‘proof of concept’. A randomised controlled trial of the 
puborectalis sling is currently ongoing to evaluate its efficacy in reducing surgical 
recurrence.  
 
During the course of this work, there has been rapid development in the field of pelvic 
floor medicine. The rise in vaginal mesh procedures saw a dramatic increase in mesh 
related complications, which led to heated debates over the use of transvaginal mesh. 
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Treatment of pelvic organ prolapse with polypropylene mesh shifted from being the 
‘silver bullet’ of transvaginal prolapse repair to withdrawal of mesh products from the 
market - products that had been clearly shown to be effective. Regrettably, political 
and legal developments outside medicine have left too little time for researchers to 
investigate the risks and benefits in individual patients to develop criteria for patient 
selection.  
 
This work hopes to contribute to the evolving literature of mesh use in pelvic 
reconstructive surgery, to investigate different types of meshes and their anchoring 
methods, and to outline an alternative operative approach in women at high risk of 
prolapse recurrence. 
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Chapter 1: Introduction 
1.1 Pelvic organ prolapse: Scope of the problem 
Female pelvic organ prolapse (FPOP) can be considered as a form of hernia, where 
female pelvic organs herniate into the vaginal canal through the levator hiatus, the 
largest potential hernia portal in the human body. Herniation of the bladder into the 
vaginal canal is known as a ‘cystocele’ or anterior vaginal wall prolapse, herniation of 
the rectum is termed  a ‘rectocele’ or posterior vaginal wall prolapse and herniation of 
the uterus is known as ‘uterine prolapse’ or ‘procidentia’ if the uterus is entirely 
exteriorised. In women who have had a hysterectomy, vault prolapse may occur. In 
the case of vault prolapse, the apex of the vagina descends into the vaginal canal, 
most often due to herniation of the small bowel into the vagina, otherwise known as 
‘enterocele’. Complete exteriorisation of the vagina is termed ‘vault eversion’. 
Amongst the various types of prolapse in Caucasians, cystoceles appear to be the 
most common followed by rectoceles, and apical prolapse (1).  
FPOP is a common condition. In a study assessing women who presented to an 
outpatient clinic for routine gynaecological care, approximately fifty percent of women 
had an anatomical finding of prolapse at the level of the hymen (2). Of 1004 women 
between 18 and 83 years old, 38% were diagnosed with stage 1, 35% with stage II 
and 2% with stage III pelvic organ prolapse (3). In another study, approximately 40% 
of women aged between 45 and 85 years old had clinical evidence of a prolapse (4). 
1 
FPOP can be asymptomatic (5, 6). In symptomatic patients, the condition may give 
rise to a vaginal lump or a dragging sensation (7), sexual dysfunction, urinary 
frequency/urgency, urinary incontinence, voiding difficulties and/or bowel symptoms 
including obstructive defecation or faecal incontinence (8-10). These symptoms can 
be debilitating and can significantly impair a women’s quality of life, both socially and 
physically (11). 
 
Apart from pessary management, surgery is the mainstay of treatment for FPOP. A 
women’s lifetime risk for prolapse surgery ranges between 10 – 20% (5, 12). In the 
United States, the annual cost of outpatient care for pelvic floor dysfunction between 
2005 to 2006 was in the order of $300 million (13) and between 1979  to 2006, 
surgical repair for prolapse was amongst the most common inpatient procedure 
performed in women over the age of 70 (6). As the population continues to age in 
developed countries, pelvic organ prolapse and its related morbidities will place an 
increasing burden on the healthcare system (14).  
 
Apart from the high prevalence of primary pelvic organ prolapse, prolapse recurrence 
after surgical repair is another significant clinical issue. It has been estimated that 
one third of patients require reoperation (5). Amongst the different forms of FPOP, 
cystocele seems to be the most difficult condition to manage with a recurrence rate 
after traditional anterior vaginal wall repair between 40 and 63% (15-18) and up to 90% 
in some women (19). Due to the high rate of prolapse recurrence, clinicians 
continually search for repair methods that would render stronger and more robust 
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support to the pelvic organs whilst retaining or restoring the functionality of the vagina 
for intercourse as well as normal bladder and bowel function.  
1.2 Pelvic organ prolapse: Theories of aetiology 
Over the years, a number of authors have published on aetiology and risk factors for 
pelvic organ prolapse and prolapse recurrence. However, the mechanisms leading to 
the development of FPOP remain poorly understood. The causation of FPOP is likely 
multifactorial, a result of a combination of risk factors which may vary between 
patients. Conceptually, different levels of pelvic organ support have been described, 
with complex interactions between the levator ani muscle, the vagina, the fascia and 
ligaments of the pelvic floor contributing to pelvic organ support. There have been 
several postulated theories of pelvic organ prolapse development.  
Bonney (20) first suggested the possibility of pelvic organ descent secondary to the 
forces placed on the pelvic floor by increased abdominal pressures whilst DeLancey 
proposed the ‘Ship in the Dock’ hypothesis, where the interaction between pelvic 
floor muscles and pelvic ligaments was believed to play an important role in 
pelvic organ support . In this hypothesis, intact pelvic floor muscles help to 
maintain near-closure of the levator hiatal area, thus minimising the load and 
tension placed on pelvic ligaments and fascia, which attach the organs to the 
pelvic sidewall. A defective pelvic floor muscle in this scenario would allow the 
hiatus to widen, thus allowing the weight of the pelvic organs to put excessive 
loads on pelvic ligaments and fascia. These might fail over time, leading to FPOP. 
3 
'H/DQFH\ IXUWKHU GHVFULEHG WKUHH OHYHOV RI DQDWRPLFDO VXSSRUW RI WKH SHOYLF
VWUXFWXUHV suspending the pelvic organs (see Fig 1). These three levels of 
support were: Level 1, which consisted of the uterosacral and cardinal ligaments. 
They contribute to suspension of the upper vagina by attaching it to the pelvic 
sidewall; Level 2 contributes to support of the mid-portion of the vagina, where the 
paracolpium attaches the vagina laterally and more directly to the pelvic sidewall/
arcus tendineus fasciae pelvis (ATFP); Level 3 involves supports to the lower 1/3 of 
the vagina, where it directly attaches to the surrounding structures without any 
intervening paracolpium. It was believed that failure at different levels of pelvic 
musculo-fascial support may result in the development of different forms of pelvic 
organ prolapse (21). For instance, failure of Level 1 support may lead to uterine or 
vault prolapse while failure of Level 2 support may contribute to cystocele 
formation. The DeLancey view of prolapse aetiology clearly seems to have merit in 
explaining cystocele and uterine support; it is however quite insufficient to 
explain posterior compartment prolapse. 
Fig 1: Current anatomical consideration for prolapse. From Lim VF et al, Recent 
studies of genetic dysfunction in pelvic organ prolapse: The role of collagen defects. 
Aust NZ Journal Obstet Gynecol. 2014;54(3):198 – 205 with permission. 
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Richardson, on the other hand, described potential mechanisms for prolapse 
development based on the theory of defects within the fibromuscular layer, the 
endocervical fascia between the vagina, bladder and the rectovaginal septum or 
Denonvillier’s fascia between the vagina and rectum. He postulated that cystoceles 
or rectoceles developed due to isolated defects within these connective tissue 
structures. He claimed that closure of the defect was associated with successful 
surgical treatment of prolapse in 91.7% at 3 to 48 months after surgery (22).  Site-
specific defect repair of the rectovaginal septum in particular was shown to have high 
surgical success in the treatment of rectoceles (23). The latter has been confirmed in 
a recent publication of the unit by the author on a surgical audit of the technique in 
rectocele repair where anatomical cure reported in 85% on clinical examination and 
80% on ultrasound assessment (24). It appears that for posterior compartment 
prolapse the Richardson hypothesis of prolapse pathophysiology does indeed hold 
true. However, this does not seem to be the case for the anterior and central 
compartments.   
1.3 Pelvic organ prolapse: risk factors 
There have been multiple studies on potential risk factors for FPOP. FPOP is likely 
multifactorial secondary to a combination of risk factors. Risk factors for POP may 
include aging, menopause, ethnicity, genetic predisposition and connective tissue 
disorders. Other risk factors may include body mass index, parity, mode of delivery, 
birth weight of the baby, length of second stage, constipation and other conditions 
5 
that are associated with a chronic elevation of intra-abdominal pressures, such as 
chronic lung diseases.  
1.3.1a Age and Menopause 
There seems to be an assumption that older women are at a higher risk of prolapse 
(25) and that menopause may contribute to poorer tissue elasticity and quality 
contributing to prolapse symptoms (26). However evidence in the literature is 
conflicting. Epidemiological studies have shown associations between age and 
prolapse (1, 27); however a study by Nygaard et al found that the rate of symptomatic 
prolapse was lowest in young women and then the rate plateaus in patients over the 
age of 40. The rate of prolapse was 1.6% in those 20 – 39 years old, 3.8% in 40 – 59, 
3% in 60 – 79 and 4.1% in over 80 (28). In a study by Handa et al (29), 412 women 
were assessed every 2 years for over 8 years and the authors found the incidence of 
a new cystocele was 9%, rectocele was 6% and uterine prolapse was 2%. 
Interestingly, Handa et al also found a relatively high probability of regression of POP 
in their cohort. The annual rates of regression from stage 1 were 24% for cystocele, 
22% for rectocele and 48% for uterine prolapse. In a large cohort of women 
symptomatic of pelvic floor disorders, an increase in organ descent was noted in 
premenopausal women; however, the relationship between age and anterior or 
posterior compartment prolapse was reversed after menopause (30). In studies on 
the association between age and prolapse recurrence, Whiteside et al have shown 
prolapse recurrence was more commonly seen in younger women (<60 years) and in 
those with more advanced preoperative pelvic organ prolapse staging (31). Diez-Itza 
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et al confirmed these findings in a study on women 5 years after vaginal prolapse 
repair (31, 32).  
 
In regards to menopause, in a retrospective study on 311 women seen in a tertiary 
urogynaecological centre, there was no evidence for menopausal age as an 
independent predictor of any symptom and sign of pelvic organ prolapse and pelvic 
floor muscle function (33). Current use of hormonal therapy was shown to have a 
minor negative effect on pelvic organ support (34). These findings suggest that 
menopause is unlikely to play a major role in FPOP.  
 
1.3.1b Ethnicity  
 
Ethnicity has been thought to play a role in the pathogenesis of pelvic floor 
dysfunction for several decades (35-41).  Data from epidemiological studies and from 
cadaver dissection suggested that African and Asian women might be less 
susceptible to FPOP compared to Latina and Caucasian women. African-American 
women were shown to be four to five times less likely to present with symptomatic 
prolapse and when compared with Caucasian, African-American women had 1.4-fold 
less risk of stage 2 pelvic organ prolapse (42). In a cadaveric study, Zacharin 
demonstrated superior anatomical pelvic support in Chinese compared to Caucasian 
women (37). Ultrasound studies have also confirmed less pelvic organ mobility in 
Asians compared to Caucasians (41, 43). The latter study further showed that the 
levator hiatal area was significantly smaller, and the pubovisceral muscle significantly 
thicker in Asians compared to Caucasians. Contrary to available data, a comparative 
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pelvic floor ultrasound study of young nulliparous Ugandans and Caucasians found 
that all measurements of hiatal dimensions and pelvic organ descent were 
significantly higher among the Ugandans despite no significant difference between 
the two groups in pelvic floor muscle thickness and levator hiatal area measurements 
(44). In a South African study on women symptomatic of pelvic organ prolapse, Black 
South Africans were shown to have significantly greater levator hiatal area size and 
greater pelvic organ decent on ultrasound as compared to other ethnic groups (45). 
The role of ethnic contribution to prolapse development is complex.  Factors such as 
genetics, lifestyle, diet and nutrition may also play a role. Differences in social 
background, educational level, degree of bother by prolapse (46), health-seeking 
behaviour and ease to access medical facilities might further contribute to the racial 
differences in relation to FPOP reported in the literature. 
Interestingly, ethnicity was not shown to be a risk factor for reoperation after surgery 
for POP recurrence or urinary incontinence (47, 48). 
1.3.1c Genetic predisposition and collagen dysfunction 
Women with a strong family history of POP appeared to be at an increased risk of 
prolapse compared to those without (OR 2.58, 95% CI 2.12 – 3.15) (49). Certainly, in 
studies of twin siblings, there was strong evidence to demonstrate that heritability 
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contributed to the occurrence of pelvic organ prolapse (50). In a recent meta-analysis, 
family history was also shown to be a risk factor for recurrence (51). 
There is a known correlation between collagen-associated disorders, such as Ehlers-
Danlos and Marfan’s syndrome, and increased prevalence of pelvic organ prolapse 
and prolapse recurrence (52-54). Women with prolapse were at significantly greater 
risk of abdominal hernias compared to controls (31.6% vs 5%, n = 120, p = 0.002) 
(55). It appeared that alteration in the quality of collagen metabolism and tissue 
integrity might give rise to weaker fascial support (56); hence, it is plausible for 
genetics to play a part in POP development. Studies that analysed collagen 
components within the uterosacral and cardinal ligaments of women with prolapse 
found a decrease in total collagen structure but an increase in collagen III/I ratio. 
Type III collagen is more flexible and elastic while type I collagen has higher tensile 
strength due to its longer and thicker fibres (57). It has been suggested that 
increased elasticity of the pelvic floor tissues may lead to impaired pelvic organ 
support. However, this and similar claims based on studies such as the one quoted 
remain hypothetical as it is impossible to determine whether the observed changes 
reflect the cause or effect of POP.  
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1.3.2 Modifiable risk factors for pelvic organ prolapse 
1.3.2a Obesity and Chronic increase in intra-abdominal pressures  
Conditions associated with a chronic increase in intra-abdominal pressure e.g. 
constipation, chronic pulmonary disease and obesity, may increase load bearing on 
the pelvic floor and in turn, may impair pelvic organ support in the long term. Chronic 
pulmonary disease and constipation have been shown to be associated with pelvic 
floor dysfunction (58-60). It has also been suggested that repeated straining on 
defecation may cause stretching of the pudendal nerve, leading to possible 
progressive neuropathy and dysfunction in patients with chronic constipation (61, 62). 
However, the role of these conditions in the pathogenesis of POP remains unclear 
with conflicting results shown in the literature (3, 63). 
As opposed to the ambiguity of the effect of chronic straining and prolapse 
development, obesity has been shown to be a risk factor for FPOP. The risk of FPOP 
LQ ZoPHQ ZLWK D EoGy PDVV LQGH[ %0,  NJP2 was shown to increase by 2.5-fold 
compared to women with a normal BMI (1, 28, 64-66). It was shown that of those with 
a BMI between 25 – 30kg/m2, the rate of pelvic organ prolapse was approximately 30 
– 40% whilst in those whose BMI was greater than 30kg/m2, the rate of FPOP was in
the order of 40 – 75% (1). A recent meta-analysis (67) of over 20 studies evaluating 
the effect of BMI and pelvic organ prolapse has shown the risk ratios of developing 
prolapse to be at least 1.36 (95% confidence interval, 1.20 – 1.53) in those who were 
overweight, and at least 1.47 (95% confidence interval, 1.35 – 1.59) in obese women . 
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There was also some evidence for the association between obesity and prolapse 
recurrence (32, 51). 
7he association between prolapse and obesity KRZHYHU is likely to be 
complex. There is evidence that being either primarily or exclusively overweight 
affects the posterior compartment (68). 
1.3.2b Childbirth 
Epidemiological and observational studies have shown that parity and vaginal 
delivery are significant risk factors for pelvic organ prolapse (3, 65, 66). Multiple 
studies have identified childbirth as the single most reliable predictor of FPOP in later 
life (1, 58, 69, 70). In a prospective study of 17,032 women who attended family 
planning clinics, childbirth was the strongest risk factor for FPOP and the risk 
increased with parity (27). Women with one child were 4 times and those with two 
children were 8.4 times more likely to require hospital admission for prolapse. The 
association between parity and FPOP may be partially due to the mechanical and/or 
hormonal effects of pregnancy on pelvic floor function. It is plausible that the gravid 
uterus may cause increased distension of the levator hiatus and pelvic organ descent. 
Furthermore, prolonged exposure to pregnancy hormones such as progestogens and 
relaxin may favour elastolysis and ultimately result in pelvic floor dysfunction (71). 
Collagen remodelling in response to pregnancy may also alter the mechanical 
strength of the pelvic floor and contribute to pelvic floor dysfunction (72). 
Unfortunately to date, the role of pregnancy in the pathogenesis of FPOP remains 
unclear and continues to require ongoing research. 
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Current data in the literature suggests that vaginal delivery may result in significant 
pelvic floor trauma, especially as the fetus passes through the birth canal. The 
disruption of pelvic musculature and fascia through this process clearly contributes to 
the pathogenesis of pelvic organ prolapse. Several long-term population studies 
found caesarean section to confer a reduced risk of pelvic organ prolapse in later life 
(66) compared to vaginal birth (65, 73, 74). Forceps delivery, on the other hand, was 
associated with an increased risk of FPOP (73-76). Trauma to the pelvic floor 
secondary to vaginal delivery, especially after forceps, may be the underlying 
explanation. There is now growing evidence to suggest that levator ani muscle injury 
is probably the missing link between childbirth and FPOP (77).  
1.3.2c Levator trauma 
The levator ani muscle plays an important role in pelvic organ support. The main 
component of the muscle and the most important for pelvic organ support seems to 
be the puborectalis muscle. This muscle structure forms a V-shaped sling around the 
anorectum posteriorly and attaches to the inferior pubic rami on both sides. The area 
bordered by the puborectalis muscle posteriorly and the symphysis pubis anteriorly is 
known as the levator hiatus, which is the largest potential hernia portal in the human 
body, through which pelvic organs herniate to cause FPOP. Both the integrity of the 
puborectalis muscle and the size of the levator hiatus are important determinants of 
pelvic organ support (78). 
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Abnormal levator ani anatomy in women with genital prolapse was first described by 
Halban and Tandler in 1907 (79); the first illustration of levator trauma is found in a 
textbook by De Lee published in 1938 (80). Over a decade later, Howard Gainey 
reported detachment of the pubococcygeus muscle (which we would call the 
puborectalis muscle and the condition, levator avulsion) on clinical examination in 
approximately 20% of patients following vaginal delivery (81).  Dietz et al were the 
first to show levator avulsion was a result of vaginal delivery in a peripartum imaging 
study (82, 83). The first case report of levator avulsion diagnosed in the delivery suite 
was published in 2007, when the same author showed the clinical and imaging 
documentation of a right-sided levator avulsion in a patient with a large vaginal tear 
(82), see Fig 1.1. It was in 2009 when the first anatomical confirmation of levator 
muscle damage was reported. In this study, a gross unilateral levator muscle defect 
was demonstrated on MRI and serial histological and histochemical stained sections 
of the pelvis in a 69-year-old multiparous patient (84). 
Fig 1.1: Major levator trauma as seen through a large vaginal tear after vaginal 
delivery (left), on ultrasound (middle) and on MRI (right) 3 months post-partum. 
Reproduced with permission from Dietz et al, ANZJOG 2007.  
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Computer modelling studies of childbirth have shown that the puborectalis muscle 
has to stretch 2 – 3.5 times its resting length during crowning of the baby’s head (85, 
86). An imaging study using the 3D ultrasound data of 224 pregnant nulliparous 
women showed that the required muscle stretch at vaginal delivery might in fact vary 
widely in the general population. The stretch ratio was reported to range from 0.62-
2.76 for dimensions at rest and 0.24-2.42 for dimensions on maximal Valsalva (87). 
Hence, it is not surprising that up to 36% of women may sustain levator avulsion after 
vaginal birth (77). Reported risk factors of levator avulsion include increasing 
maternal age, increasing head circumference and the length of 2nd stage (88-90). 
Forceps is an important risk factor and was shown to be associated with a 3 – 4 fold 
increased risk of levator avulsion (91, 92). Ventouse delivery, on the other hand, 
confers a risk comparable to that of normal vaginal delivery (77). 
In addition to macroscopic muscle injury, vaginal delivery may also result in 
microscopic or occult pelvic floor muscle trauma. Research in muscle physiology 
showed that substantial ultrastructural trauma, up to and including disruption of 
sarcomeres, was likely to occur if skeletal muscle distended to beyond 1.5 times its 
original length (93). Given the degree of muscle lengthening at vaginal delivery, it 
would therefore be plausible to accept that some form of occult muscle injury might 
occur even if the muscle remained grossly intact. In a peripartum ultrasound study, 
the hiatal area was shown to enlarge by >20% on Valsalva in 28.5% of primiparae 4 
months after vaginal delivery (94) and this change to the levator distensibility might 
be irreversible (95). Increasing the length of 2nd stage was reported to be a risk factor 
for abnormal levator distensibility and epidural block might have a protective effect 
(92). Studies in young healthy nulliparous women and in women symptomatic of 
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pelvic floor dysfunction have shown an association between hiatal area and pelvic 
organ descent (96, 97). Microscopic levator trauma may cause an abnormally 
distensible hiatus or ‘ballooning’ and this injury may be another mechanism to explain 
the association between childbirth and FPOP.  
Both levator avulsion and an abnormally distensible hiatus or hiatal ballooning have 
been shown to be independent risk factors for POP (98). A growing body of evidence 
has demonstrated an association between levator avulsion and POP, especially the 
anterior and central compartments (76, 99-102).  Depending on the types of prolapse, 
it was reported that unilateral avulsion conveyed an odds ratio between 1.88 and 
2.87 for symptoms and signs of prolapse, and between 2.22 and 5.31 in those with 
bilateral avulsion. Levator avulsion was found to be associated with increased muscle 
distensibility, an abnormally distensible hiatus or ballooning and reduced muscle 
contraction (103). These mechanisms are likely to underlie the association between 
avulsion and FPOP. 
FPOP is a form of hernia and the levator hiatus is the hernia portal. The bigger the 
hernia portal is, the more likely that women will have signs and symptoms of POP as 
shown in several studies (98, 104-106). It was estimated that for each cm2 of hiatal 
area enlargement on Valsalva, the risk of symptoms and signs of prolapse may 
increase by 6-11% (98). 
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1.4 Pelvic organ prolapse: Treatment options   
 
1.4.1 Conservative therapy 
 
Conservative treatment is usually regarded as the appropriate first step in the 
management of FPOP. It encompasses non-surgical methods including lifestyle 
intervention, weight loss, use of vaginal pessaries as well as pelvic floor 
physiotherapy (107). Randomised controlled trials have found patients with FPOP 
experienced improvement in their overall symptom of prolapse following intensive 
individualised pelvic floor physiotherapy (108-110). In a study of 109 women with 
pelvic organ prolapse ranging from stage 1 to 3, 19% of patients demonstrated one 
POPQ stage improvement as well as sonographic improvement in pelvic organ 
support with individualised pelvic floor muscle training sessions by a trained 
physiotherapist (111). In a meta-analysis of 13 trials assessing the impact of PFMT, 
the findings suggested a reduction in prolapse symptoms as well as an improvement 
in objective prolapse stage (risk ratio 1.7, 95% CI 1.19 – 2.44) (112).  
 
Insertions of objects and devices into the vagina for prolapse reduction have been 
used for millennia. A Greek physician recommended insertion of half a pomegranate 
into the vagina to aid support whilst Soranus advocated insertion of a linen tampon 
soaked in vinegar and a piece of beef (113). Only in the early sixteenth century did 
medical doctors start to utilise purpose-made pessaries and these ranged from oval 
to round shapes.  To date, there are a variety of pessaries of different kinds ranging 
from simple ring and donut shapes to more complex structures such as the Gellhorn 
or Shelf pessaries. In general, pessary treatment has been regarded to be 
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acceptable, both by clinicians as well as by patients (114). Patients who are more 
likely to fail pessary treatment tend to be of younger age (114, 115), those with 
advanced prolapse (115) or have had previous hysterectomy (116) and those with 
D larger levator hiatal area and levator avulsion (117). Pessary treatment appears to 
be successful (118, 119) however, the rate of long term use of pessaries remains 
low (120). In a study of 273 women fitted with a ring pessary, only 14% continued 
with pessary use for 7 years or longer (120). More than 50% of patients 
experienced complications such as bleeding, expulsion, vaginal discharge, pain 
and constipation and approximately 30% of patients elected for surgical treatment.  
1.4.2 Pelvic organ prolapse – surgical treatment 
Surgery is commonly employed for the management of symptomatic POP if 
conservative treatment is not desired or if it has failed. The earliest surgical treatment 
for POP was relatively simple, including suturing the labia together or removing 
pieces of vaginal mucosa prior to suturing the edges together to reduce vaginal 
calibre. The advent of anaesthesia and antimicrobials in the mid-19th century led to 
improved safety of surgery, such that it became feasible to surgically fix uterovaginal 
prolapse (121). Surgical management of FPOP evolved over the years with the aim 
to improve surgical outcomes.  Synthetic materials were introduced to augment 
prolapse repair back in 1955 when Moore et al first used tantalum mesh for anterior 
compartment prolapse repair (122). In spite of this effort, recurrence remained 
common with approximately one third of prolapse procedures performed for 
recurrence (5).  
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Among the different forms of POP, cystocele can be a particularly difficult condition to 
manage with a recurrence rate after traditional repair between 40 to 63% (17, 19, 20). 
In 2003-2004 anterior vaginal meshes anchored via the transobturator route (Anterior 
Prolift™ Ethicon, Sommerville, NJ USA and Perigee™ AMS, Minnetonka, MN, USA) 
were invented in France by Prof Bernard Jacquetin and in Australia by Prof Ajay 
Rane and Prof Malcolm Frazer and marketed through US biomedical corporations.  
During the research into mesh kit development, I had the opportunity to interview 
the co-creators of the transobturator mesh kit anchoring system, Prof Malcolm 
Frazer and Prof Ajay Rane. These two senior urogynaecologists were 
determined to improve the surgical repair methods for women with cystocele. 
The innovation of using transobturator anchoring was based on the concept 
of the transobturator midurethral slings, introduced in 2002. Placement of a 
MonarcTM sling involved passage of a helical needle trocar through the infero-
medial aspect of the obturator foramen to retrieve a strip of polypropylene mesh, 
fed through a suburethral incision that allowed the creation of paraurethral tunnels. 
The sling sat midurethrally, between the urethra and vagina. This development had 
familiariVed gynaecologists worldwide with the obturator foramen as a surgical field, 
and had established the safety of using this area for the passage of mesh arms. 
According to Prof Rane, in the year 2000 he was in Clermont-Ferrand, France, 
where he observed Prof Bernard Jacquetin’s insertion of a MonarcTM sling and 
subsequent cadaveric dissection. In 2003, Prof Frazer and Rane developed the idea 
of bilateral transobturator anchoring arms for an anterior compartment mesh, 
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improving on the concept of suture fixation to the pelvic sidewall, a clearly ineffective 
method. Initially, the MonarcTM sling was intended to provide the inferior anchoring 
arms, while an additional superior strip of mesh would provide the cranial anchoring 
mechanism.  
This was initially called Total Anterior Wall Shelf or Total Anterior Reconstruction 
System (TAWS/TARS, Frazer) or Transobturator Anterior Repair Approach (TARA, 
Rane), see Fig 1.2. A further novel surgical idea was the ‘Obtuledge’, a specifically 
designed mesh strip that allowed for paravaginal repair to the mesh, see Fig 1.3. The 
intention of Frazer and Rane was to design a commercially produced mesh kit 
system that provided a robust and easily learned technique for pelvic floor 
reconstructive surgeons, combining a low degree of invasiveness with ease of 
insertion. It involved the placement of 4 limbs attached to a central mesh patch 
supporting the bladder base from the bladder neck to the apex, with the four arms 
traversing the obturator foramen. The concept was submitted to American Medical 
Systems, Minnetonka, Minnesota USA, in 2003.  
19 
Fig 1.2: Original drawing of a transobturator anchoring mesh kit system by Frazer 
and Rane in 2003, used with permission by M Frazer. 
Fig 1.3: Original drawing of a side-wall mesh anchoring device, called the “Obtuledge” 
by Prof Frazer and Rane, as a form of paravaginal mesh anchoring technique in 2003, 
used with permission by Prof Frazer.  
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A patent application was submitted by American Medical Systems in 2004 (see Fig 
1.4).  Over several months of negotiations, full recognition was given to Prof Frazer 
and Rane by American Medical Systems later that year.  
Fig 1.4: Drawing by engineers of the American biomedical company, patent 
application publication lodged in Feb 2004, US 2004/0039453, Fig 13. 
The PerigeeTM system (Fig 1.5) became available in Australia in 2004. Prof Rane 
performed the first 40 PerigeeTM mesh kits in Australia with Therapeutic Goods 
Australia (TGA) special Access Scheme permission, and this series was performed 
under local HREC approval.  
Fig 1.5: The PerigeeTM mesh kit system by American Medical Systems. Used with 
permission from Moore R and Miklos J, “Vaginal Repair of Cystocele with Anterior 
Wall Mesh via Transobturator Route: Efficacy and Complications with Up to 3-Year 
Follow-up,” Advances in Urology, vol. 2009, doi.org/10.1155/2009/743831. 
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In France, Bernard Jacquetin also developed the idea of an anterior mesh hammock. 
Prior to the year 2000, due to ongoing suboptimal prolapse repair outcomes, 
Jacquetin began to explore the concept of paravaginal defect repairs. Initially, by 
suturing to the ATFP with disappointing efficacy. He established the Transvaginal 
mesh (TVM) group to test a “TVM” mesh concept, that is, a trapezoidal mesh to 
support the bladder base, with a lateral transobturator arm. Originally, the concept 
was a single-arm design (Fig 1.6); however, due to poor stability a second 
transobturator arm was added, creating the basis for the anterior ProliftTM mesh kit. 
Fig 1.6: Anterior mesh kit system with single arm (with permission from B Jacquetin). 
Between 2000 and 2005, anterior mesh kit prototypes developed by Jacquetin were 
tested on animals and cadavers by the “TVM” group, both in Clermont-Ferrand and in 
Paris. A first patent application was lodged in 2002. In collaboration with engineers 
from Ethicon, the anterior and posterior ProliftTM mesh kit systems were patented in 
2003 (Fig 1.7).  
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Fig 1.7: Anterior and Posterior ProliftTM mesh kit systems. Figure on the left, 
reproduced with permission from Prof Jacquetin. Figure on the right, reproduced with 
permission from Fatton et al, Int Urogynae Journal 2007. 
In the following years, multiple medical device companies developed mesh kits along 
similar design lines. The most substantial deviation from the original concept of 
transobturator anchoring was the replacement of lateral transobturator arms with 
plastic anchors designed to perforate the arcus tendinous of the pelvic fascia and / or 
the obturator internus muscle and its fascia (Anterior ElevateTM, introduced in 2008), 
an approach that has not been successful. Another design change was the 
incorporation of apical anchoring to the sacrospinous ligaments as in the Anterior 
ElevateTM and UpholdTM (introduced in 2008) kits.  
The primary aim of all anterior anchored mesh kits was to provide better load 
resistance and thus, improved anatomical outcome through a minimally invasive 
approach. As a result of effective global marketing the introduction of these mesh kits 
into clinical practice was rapid. Widespread adoption occurred in spite of limited data 
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on safety and efficacy. While randomised controlled studies later found a higher 
objective cure rate with transobturator mesh repair compared to anterior 
colporrhaphy (123-125); recurrent cystocele was not uncommon and was reported in 
13% of patients at 10-month follow up in a surgical audit on the Perigee™ 
transobturator mesh.  In this study, recurrent cystocele was observed to occur dorsal 
to the anchored mesh in five women on ultrasound imaging. This was seen to be 
associated with a marked change in the mesh axis on Valsalva, which implied 
dislodgment of the superior anchoring arms (126). It was the first documentation of 
mesh failure using imaging in literature, and it also provided insight into the 
mechanisms of mesh success. Understanding both advantages and disadvantages 
in individuals was important as its use requires WKH balancing of ERWK risks and 
benefits. This was because mesh augmentation surgery is not innocuous and 
can lead to serious complications (127). 
Anatomical studies performed in the early 2000s pointed out the strong association 
between cystocele and apical prolapse (128). Some authors subsequently claimed 
that apical anchoring was essential for fixing anterior compartment descent, which 
led to the introduction of mesh kits such as the Anterior Elevate™ (American Medical 
Systems, Minnetonka, USA) in 2008. The Anterior Elevate™ is an anterior anchored 
mesh that utilised tissue anchors to the arcus tendineus fascia pelvis (ATFP) and 
sacrospinous ligaments (SSL). A different method of apical suspension is the use of 
mesh inserted through an abdominal incision called a sacrocolpopexy, which is a 
surgical procedure for vault or uterine prolapse. This procedure was shown to be 
highly effective in providing apical support but less effective for the anterior and 
posterior compartment (129), challenging the concept that apical support is important 
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for cystocele repair. This has also led to the question of whether mesh location, i.e. 
how far down the mesh is on the vaginal wall, is important for anatomical outcome.     
It is generally assumed that etiological factors for pelvic organ prolapse may also be 
risk factors for POP recurrence after surgery. However, there is limited literature 
reviewing the risk factors for prolapse and prolapse recurrence and even a fewer 
number of updated meta-analysis on this topic. Friedman et al recently reviewed 
twenty-five studies with a total of 5082 patients and an average prolapse recurrence 
rate was found to be 36%. The authors performed a meta-analysis on body mass 
index (BMI), age, preoperative stage, levator avulsion, parity, constipation/straining, 
number of compartments involved, prior hysterectomy and family history. They 
showed that levator avulsion [odds ratio (OR) 2.76, P < 0.01], preoperative stage 3–4 
(OR 2.11, P < 0.001), family history (OR 1.84, P = 0.006), and hiatal area (OR 
1.06/cm2, P = 0.003) were significant predictors for recurrence (51).  
The findings of this meta-analysis suggested that secondary repair of levator avulsion 
may offer benefit. This procedure involves reconnecting the puborectalis muscle back 
to the os pubis. Dietz et al were the first to report the outcomes of a pilot study on 
surgical repair of levator avulsion in 17 women who had concomitant prolapse repair 
for symptomatic POP.  The authors showed that while direct surgical repair of levator 
avulsion was feasible at the time of prolapse repair, its effect on prolapse recurrence 
and hiatal dimensions was relatively disappointing (130). Five patients had prolapse 
recurrence beyond the hymen and the mean hiatal area on Valsalva was reduced 
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from 36.84cm2 to 30.71cm2 (p< 0.001), still well above the limit of normal at 25cm2
(96, 97).
The findings of an association between hiatal area and prolapse recurrence can be 
explained by basic physical considerations. As Pressure = Force / Area, the forces 
acting on pelvic support structures are directly proportional to the size of the hiatus 
(see Fig 1.8). In other words, the forces acting on pelvic floor structures are likely to 
be directly proportional to intra-abdominal pressure and hiatal area. The wider the 
levator hiatus is, the more load is placed on pelvic organ support, which may be 
formed by native tissue, surgical sutures or mesh structures in prolapse repair. 
Hence, traditional repair techniques may fail, resulting in prolapse recurrence. It is 
plausible that surgical measures aimed at reducing the hiatal area might decrease 
prolapse recurrence by reducing the load on pelvic organ support.     
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Fig 1.8: Modelling of pelvic floor loading relative to abdominal pressure and hiatal 
area on Valsalva. The force generated by a given intra-abdominal pressure will vary 
markedly, depending on hiatal area on Valsalva.            20 cmH2O;             40 cmH2O; 
        60 cmH20;            80 cm H20;             100 cmH20. Reproduced with 
permission from Dietz, UOG 2012; 40: 495 – 503. 
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1.6 Aims of thesis 
 
From the previous discussion, it is evident that successful surgical treatment of FPOP 
is challenging. This may be largely due to a lack of understanding of the 
pathophysiology of FPOP, and resulting problems with matching a given patient to 
the most appropriate procedure. The constant drive to improve surgical outcomes 
among pelvic reconstructive surgeons led to the adoption of mesh technology without 
sufficient safety and efficacy testing. In the past this would have been remedied by 
ongoing development, much of it by trial and error, over decades, as occurred with 
other innovative medical technologies such as hip replacements. The increasing risk-
adversity of Western society has however made such an approach quite 
unacceptable.  
 
It is evident that a different approach should have been followed, taking into account 
modern research ethics and regulations. Unfortunately, the ever-increasing 
compliance burden associated with human research and the adversarial and highly 
lucrative nature of Western, (especially US) tort law have now cut short efforts at 
optimisation of mesh design and patient selection, at least for the time being. 
 
Several RCTs have confirmed the efficacy of anterior transvaginal mesh in improving 
anatomical outcomes compared to traditional native tissue repair; however, 
insufficient efforts were made to optimise patient selection. This led to the 
widespread, nonselective use of transvaginal mesh in prolapse surgery without 
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appropriate diagnostic efforts in order to balance the risks and benefits in individual 
patients.  
 
There is a growing body of evidence identifying the role that the levator ani muscle 
has for pelvic floor support. Levator avulsion and hiatal ballooning have been 
identified to be important risk factors for POP recurrence. Hence any novel surgical 
technique should first be tested in women at high risk of recurrence, that is, in those 
with an abnormal pelvic floor. Surgical techniques that compensate for the effects of 
abnormal levator ani muscle structure would be expected to improve surgical 
outcomes; hence the development of such techniques should have a high priority. 
 
This work was undertaken to test the following hypotheses: 
 
1. Augmentation for anterior compartment prolapse is associated with 
better outcome as compared to traditional anterior colporrhaphy.  
 
Hypothesis 1 is tested in Chapter 3. In this retrospective cohort study, subjective and 
objective outcomes including ultrasound quantification of prolapse, following anterior 
colporrhaphy with and without mesh use for anterior compartment prolapse were 
assessed. The study further evaluated the efficacy of anterior anchored mesh in 
women with and without levator avulsion. The study resulted in Paper 1: Wong V, 
Shek KL, Goh J, Krause H, Martin A, Dietz HP. Cystocele recurrence after anterior 
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colporrhaphy with and without mesh use. European Journal of Obstetrics & 
Gynecology and Reproductive Biology. 2014;172:131-5. 
 
2. Levator avulsion is a risk factor for prolapse recurrence after anterior 
mesh repair. 
 
Hypothesis 2 is tested in Chapter 4. In this retrospective analysis of data obtained 
through clinical audits on anterior transobturator mesh procedures (Perigee™ system, 
American Medical Systems, Minnetonka, MN, USA and Anterior Prolift™ system, 
Gynecare/Ethicon, Somerville, NJ, USA) performed at three tertiary urogynaecology 
centres. Levator avulsion was investigated as a risk factor for prolapse recurrence 
following anterior colporrhaphy with mesh reinforcement. The study resulted in Paper 
2: Wong V, Shek K, Rane A, Goh J, Krause H and Dietz H. Is levator avulsion a 
predictor of cystocele recurrence following anterior vaginal mesh placement? 
Ultrasound in Obstetrics & Gynecology 2013; 42: 230-234. 
 
3. Vaginal mesh with apical anchoring to the sacrospinous ligament is 
associated with improved outcomes compared to mesh implant with 
sidewall fixation. 
 
Hypothesis 3 is tested in Chapter 5.  In an observational study using data obtained in 
one internal and two external surgical audits of anterior compartment mesh 
conducted at three tertiary urogynaecological centres, subjective and objective 
outcomes of two mesh kits, the Perigee™ and Anterior Elevate™ were compared. 
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This resulted in Paper 3: Wong V, Shek K, Rane A, Lee J, Rosamilia A and Dietz H. 
A comparison of two different mesh kit systems for anterior compartment prolapse 
repair. Australian and New Zealand Journal of Obstetrics and Gynaecology 2014; 54: 
212 – 217. 
 
4. Abdominally placed mesh for apical or uterine prolapse is effective for 
anterior compartment support. 
 
Hypothesis 4 is tested in Chapter 6. In an external surgical audit of laparoscopic 
sacrocolpopexy performed by an experienced laparoscopic surgeon, the efficacy of 
the procedure in anterior compartment support was evaluated. The correlations 
between mesh location and mobility and prolapse recurrence on ultrasound imaging 
were studied. This study resulted in Paper 4: Wong V, Guzman Rojas R, Shek K, 
Chou D, Moore KH and Dietz HP. Laparoscopic sacrocolpopexy: how low does the 
mesh go? Ultrasound in Obstetrics & Gynecology 2017; 49: 404-408.  
 
5. Surgical placement of a piece of mesh sling around the puborectalis 
muscle safe and effective to reduce levator hiatal area. 
 
This hypothesis is tested in Chapter 7. In a pilot study on women with symptomatic 
POP and hiatal ballooning, the safety and efficacy of a novel technique, the 
Puborectalis Sling, in reducing hiatal area was evaluated. This study resulted in 
Paper 5:  A pilot study on surgical reduction of the levator hiatus - the Puborectalis 
Sling. Wong et al, in process of submission for publication.  
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6. Should mesh continue to be made available to pelvic reconstructive 
surgeons? 
 
 
This question was investigated in Chapter 8. In an opinion piece, current evidence for 
the use of transvaginal anterior anchored mesh in pelvic reconstructive surgery is 
detailed. I opposed a ban of mesh since it is now quite clear that women with levator 
avulsion are likely to benefit with mesh augmentation for prolapse repair. This opinion 
was published as Paper 6: Wong, V., & Shek, K. L. (2017). The mesh debate: 
Transvaginal anterior anchored mesh should not be abandoned. Australian and New 
Zealand Journal of Obstetrics and Gynaecology, 57(1), 105-107. 
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Chapter 2: Methodology  
 
This work, apart from Paper 6, incorporates several studies on patients after prolapse 
repairs. Paper 6 is an opinion piece, part of an invited debate in the pages of the 
premier journal in the field of urogynaecology that is based on a literature search of 
the current scientific evidence to examine the role of anterior transvaginal mesh in 
pelvic reconstructive surgery. Patients in Papers 1 to 4 were seen in the context of 
surgical audits. Paper 5 is a prospective observational study on women enrolled in an 
experimental surgical multicentre trial. All studies were approved by local human 
research ethics committees as stated in the corresponding publications.   
 
Patients in this work were seen at multiple centres in Australia including Nepean 
Public Hospital, Penrith NSW; Royal Prince Alfred Hospital, Newtown NSW; St 
George Private Hospital, Kogarah NSW; Waverley Private Hospital, Melbourne VIC; 
Greenslopes Private Hospital, Brisbane QLD and Mater Hospital, Pimlico, Townsville 
QLD. They all underwent a standardised interview, clinical examination and 
translabial ultrasound imaging as detailed below. Patients enrolled in the prospective 
surgical trial in Paper 6 were also interviewed and assessed preoperatively.  
 
2.1 Interview 
During the interview, basic demographic data including past obstetric history, height, 
weight, history of previous pelvic surgery and surgery performed after the index 
procedure were obtained. Patients were asked about recurrent symptoms of prolapse 
defined as a vaginal lump or a dragging sensation. Lower urinary tract and bowel 
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symptoms including stress and urge urinary incontinence, urinary frequency, voiding 
difficulties, constipation, obstructed defecation and faecal incontinence were also 
investigated. Sexual dysfunction, in particular dyspareunia, was noted. Patients were 
asked if they were satisfied with the surgical outcome and to rate overall symptomatic 
outcome as cured, improved, same, worse or uncertain. A datasheet used to 
evaluate patient outcome can be found in Appendix 1.  
2.2 Clinical examination 
Over the years, a number of staging systems have been described to quantify FPOP 
clinically, starting with the one by Porges in 1963 (1-4). These systems, however, 
share the same problem in that they are only a description of changes in surface 
anatomy and in that they provide no information as to the nature of the prolapse. As 
an example, a posterior compartment prolapse can either be due to a true rectocele, 
an enterocele, perineal hypermobility or rectal intussusception (5). Unfortunately, 
none of those systems have been evaluated properly as a test for the prediction of 
symptoms of prolapse, nor have they been validated against imaging until recently. 
Nevertheless, the last such system, the prolapse quantification system of the 
International Continence Society (POP-Q) has been widely adopted and has become 
the standard method of describing and assessing clinical prolapse, see Fig 2.1 (6). It 
is also the quantification system used in this thesis. Using the POPQ, gh (genital 
hiatus), pb (perineal body) and maximal descent of six points on the vaginal surface 
were measured relative to the hymenal remnant on Valsalva, in the dorsal lithotomy 
position after bladder emptying.  
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Fig 2.1: The POPQ system involves assessment of six points (points Aa, Ba, Ap, Bp, 
C, D) as well as points gh (genital hiatus), pb (perineal body) and tvl (total vaginal 
length). Each points are assessed on Valsalva except for TVL. Reproduced with 
permission from Bump et al, Am J Obstet Gynecol 1996; 175 (1): 10-7. 
 
Until recently, there was a lack of a definition of significant POP (i.e. degree of pelvic 
organ descent) that is predictive of symptoms. The National Institutes of Health (NIH) 
Workshop on Standardisation of Terminology for Researchers in Pelvic Floor 
Disorders recommended an arbitrary definition using POPQ stage 2, i.e. pelvic organ 
descent to 1cm above to 1cm below the hymen as the cut-off to define significant 
POP (7). In this thesis, the same cut-off was used to define significant POP and 
recurrent pelvic organ prolapse. However, it is acknowledged that there is no general 
consensus on the definition yet, and that it is very unlikely to be optimal. Using 
Receiver Operator Characteristic statistics, Dietz et al recently showed that a cut-off 
of 0.5cm above the hymen in the anterior and posterior compartment, and 4cm above 
the hymen in the apical compartment were most predictive for symptoms of prolapse, 
i.e. a lump/dragging sensation (8). Barber et al. gives absolute priority to subjective 
outcomes and argues that definitions of treatment success should require patients be 
free of symptoms of prolapse postoperatively (9). However, as many patients with 
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recurrent POP are asymptomatic (10), POP symptoms do not seem to be optimally 
sensitive as outcome measures of surgical success. Furthermore, the basic principle 
of prolapse repair is to restore normal anatomy. We have therefore used a stricter 
definition based solely on anatomical assessment on clinical and on ultrasound 
examination to define surgical success in this work.    
2.3 Pelvic floor ultrasound imaging 
2.3.1 Technique 
The advent of ultrasound technology has revolutionised the assessment of the pelvic 
floor. Use of imaging in Urogynaecology has a history that dates back to the 1920s. 
Radiological techniques were first used to describe bladder appearance and descent, 
and later for prolapse. The introduction of B mode real-time ultrasound offered an 
alternative for pelvic floor assessment. Computer Tomography (CT) and Magnetic 
Resonance Imaging (MRI) were more recently developed for the same purpose (11). 
As compared to other imaging modalities, ultrasound is advantageous as it is 
inexpensive, safe, easy to perform, has high patient acceptance and is easily 
accessible to clinicians. It has superior spatial and temporal resolution compared to 
all other imaging methods. Furthermore, ultrasound is the only imaging modality that 
allows synthetic implants (e.g. meshes) to be visualised, a benefit that is of great 
relevance to this work.  As compared to the transvaginal route, translabial / 
transperineal ultrasound imaging is non-invasive, allowing real time imaging on 
dynamic manoeuvres, e.g. Valsalva or pelvic floor muscle contraction, for the 
assessment of pelvic floor functional anatomy. Today, ultrasound is increasingly used 
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in the evaluation of pelvic floor disorders especially in women with pelvic organ 
prolapse, urinary and/or faecal incontinence (11, 12). 3D/4D ultrasound has further 
facilitated pelvic floor assessment by allowing imaging in the axial plane. This results 
in the capability to assess the integrity of the levator ani muscle, its insertion to the 
pubic symphysis and the levator hiatus.  The technology allows acquisition of 
sequences of volume data blocks for archiving and later retrieval for assessment. As 
there is no 3D or 4D DICOM (Digital Imaging and Communications in Medicine) 
standard presently, proprietary software is required for post processing analysis of 
volume data. Over the last twenty years, the technique and the methodology of 
performing translabial ultrasound has been established and standardised. This work 
was performed according to the published methodology as detailed elsewhere (13). 
Translabial ultrasound imaging is performed with the patient in the supine position 
using GE Voluson systems (730 expert, 730 Pro, S6, S8, E8 and Voluson i) with RAB 
8–4-MHz transducers (GE Medical Systems, Zipf, Austria). It is imperative that 
imaging is performed after bladder emptying. Prior defecation can also be helpful as 
it has been shown that a full bladder or a full rectum may hinder pelvic organ descent 
which may lead to a false negative assessment (14). Figure 2.2 shows placement of 
the transducer on the perineum for translabial scanning and the corresponding 
schematic representation of the image obtained in the mid-sagittal view on the 
ultrasound monitor.  Volume acquisition is obtained at rest, on maximum Valsalva 
and on maximum pelvic floor muscle contraction. During data acquisition on Valsalva, 
care is taken to ensure patients do not co-activate the levator ani muscle. Levator co-
activation is common especially in young nulliparous women (15).  It occurs when 
there is triggering of a pelvic floor muscle contraction when the patient is asked to 
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bear down and is evident as shortening in the anteroposterior diameter of the hiatus 
and/or elevation of the bladder neck (16). Levator co-activation is a confounder of 
pelvic organ descent and may lead to false negative findings. During imaging, 
attention is also paid to ensure the Valsalva manoeuvre is of adequate duration. To 
achieve near maximal pelvic organ descent, a Valsalva manoeuvre should last for at 
least 5-6 seconds (17). There have been suggestions to standardise the Valsalva 
manoeuvre that involved invasive pressure measurement, for example by asking 
patients to blow into spirometer-like devices. The technique required an open glottis 
and may explain why pressures generated were very low (18, 19). In fact, it does not 
appear necessary to standardise Valsalva pressure. In a study on 75 women, Mulder 
et al showed that virtually all patients were able to generate intra-abdominal 
pressures resulting in near maximal pelvic organ descent if properly coached (20) 
arguing against the need to standardise the Valsalva pressure.  
 
It is important however that dynamic manoeuvres are repeated. At least 3 Valsalva 
manoeuvers are performed and archived. Volume data showing maximum descent is 
used for the assessment of pelvic organ prolapse and hiatal area. Post processing is 
performed at a later date, typically months or even years after image acquisition, 
using the proprietary software 4D View (GE Medical Kretz Ultrasound, Zipf, Austria), 
on a desktop personal computer blinded to all clinical data.  It has been shown that 
the published technique for translabial ultrasound imaging is highly repeatable, both 
in US volume data acquisition and in offline assessment of US parameters (21-23). 
Furthermore, translabial ultrasound measures of pelvic organ descent are strongly 
associated with symptoms of FPOP (24, 25) and have a good correlation with POPQ 
coordinates (26) further validating the technique and the methodology. 
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Fig 2.2: Transperineal placement of the ultrasound transducer (image A) and a 
schematic representation of the pelvic organs obtained in the mid-sagittal plane 
(image B). From Dietz H. Pelvic Floor ultrasound: a review. Am J Obstet Gynecol. 
2010; 202 (4): 321 – 34, with permission.  
2.3.2 Pelvic organ descent assessment 
Volume data showing the most pelvic organ descent on Valsalva is used for the 
assessment of pelvic organ descent. Pelvic organ descent is measured against a 
reference line drawn horizontally from the infero-posterior margin of the symphysis 
pubis (see Fig 2.3). Organ descent below the reference line has a negative value and 
above the reference line, a positive value.  
Using Receiver Operator Characteristic (ROC) statistics, Dietz et al have defined 
optimum cut-offs to predict symptoms of prolapse on translabial ultrasound as -10mm 
and -15mm for cystocele and rectal descent respectively (a minus sign represents 
descent below the pubic symphysis) (8). There had been no studies to determine the 
optimal cut-off for central compartment descent and zero i.e. descent to the level of 
the pubic bone, was used to define significant central compartment descent until 
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recently. In 2015, the same group showed that +15mm was the optimum cut-off to 
predict prolapse symptoms for uterine descent using ROC statistics (a plus sign 
implies descent to above the pubic bone) (25). We have adopted the same definitions 
for significant anterior and posterior pelvic organ descent or recurrent prolapse. In 
Paper 4 the old definition, i.e. descent to the level of the pubic bone, was used to 
define central compartment prolapse.  
Fig 2.3: Translabial ultrasound imaging in the mid-sagittal image on Valsalva 
manoeuvre. Orientation: top of the image is caudal; bottom is cranial, left of the 
image is ventral and right is dorsal. Pelvic organ descent is measured with the most 
dependent part of the bladder, the leading edge of the uterus and the most 
caudal part of the rectal ampulla and/or small bowel, from a reference line 
drawn horizontally through the infero- posterior margin of the symphysis 
pubis. SP = symphysis pubis, B = bladder, U = uterus, RA = rectal ampulla.  
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2.3.3 Assessment of mesh implant 
 
In Paper 4, the location and mobility of the mesh used in laparoscopic 
sacrocolpopexy was accessed. Mesh is identified on ultrasound as a highly 
echogenic structure in all three orthogonal planes (mid-sagittal, coronal and axial; 
Figure 2.4), at rest and on maximum Valsalva. 
 
 Fig 2.4: Image of the mesh in orthogonal planes; midsagittal (A), coronal (B) and 
axial (C) plane on maximum Valsalva. Mesh is indicated by arrows. From Wong et al. 
Laparoscopic sacrocolpopexy: how low does the mesh go? Ultrasound Obstet 
Gynecol 2017; 49: 404 – 08 with permission.  
 
The lowest mesh position was identified in the mid-sagittal plane on maximum 
Valsalva, with the most caudal aspect of the mesh plotted against a reference line 
drawn from the infero-posterior margin of the symphysis pubis.  Distal mesh mobility 
ZDV DVVHVVHG uVLQJ WKH IoUPuOD ¥ >;Valsalva – Xrest)2 + (YValsalva – Yrest)2] from rest to 
maximum Valsalva, where X is the horizontal distance between mesh and inferior 
symphyseal margin and Y is the vertical distance between mesh and inferior 
symphyseal margin (Fig 2.5). The distance from the distal mesh end to the bladder 
neck was also determined at rest and on maximum Valsalva. These sonographic 
measures were used to study correlations with prolapse recurrence.  
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Fig 2.5: Midsagittal image of the mesh location at rest (A) and on Valsalva (B). Mesh 
mobility is measured using the formula √[(XValsalva – Xrest)2 +(YValsalva – Yrest)2).  
X = horizontal distance from symphysis pubis and Y = vertical distance from 
symphysis pubis. Mesh as identified with arrows. From Wong et al. Laparoscopic 
sacrocolpopexy: how low does the mesh go? Ultrasound Obstet Gynecol 2017; 49: 
404 – 08, with permission.  
2.3.4 Assessment of levator hiatal area 
Two methodologies have been described for the assessment of hiatal area. This can 
be undertaken either by using an axial sectional plane, at the plane of minimal hiatal 
dimensions as identified in the mid-sagittal view, or by using a rendered volume of 1-
2cm thickness containing the plane of minimal hiatal dimensions  . The 
latter method is based on volume rendering via machine-specific software 
algorithms and provides a semi-transparent representation of all gray scale pixels 
within the ‘region of interest’. As a result, it is possible to visually trace an area 
within a three dimensional volume, even if this does infringe the rules of Euclidean 
geometry (Fig 2.6). This method using rendered volumes for area measurement was 
used in this work as it is simpler and possibly more valid (27). 
Rest Valsalva 
Mesh 
Mesh 
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Fig 2.6: Assessment of levator hiatal area using the rendered volume method. Image 
A shows a mid-sagittal view on Valsalva. The plane of minimal hiatal dimensions i.e. 
the plane where the distance between pubic bone anteriorly and the levator ani 
muscle posteriorly is shortest, is identified in this mid-sagittal view. The region of 
interest (ROI), represented by the box in A is placed to include the plane of minimal 
hiatal dimensions. The corresponding rendered volume in the axial view is shown in 
Image B. The levator hiatus is outlined by the red dotted line in B. The area 
measured here is 27.37cm2.  
2.3.5 Assessment for levator avulsion 
Levator integrity is assessed using tomographic ultrasound imaging or multislice 
ultrasound imaging as previously described (28). Tomographic ultrasound imaging 
was performed on volumes obtained at PFMC at 2.5mm slice intervals, from 5 mm 
below to 12.5 mm above the plane of minimal hiatal dimensions (Fig 2.7). Levator 
avulsion is diagnosed if the muscle insertion is abnormal showing a disconnection of 
the muscle from its bony insertion in the three central slices, i.e. slice 3, 4 and 5, such 
as a unilateral avulsion as seen in Fig 2.8.  
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In doubtful cases, we utilise the ‘levator urethra gap measurement’. The muscle 
insertion is regarded as abnormal when the levator urethra gap is >2.5 cm (29). This 
method of diagnosing levator avulsion has been shown to be valid and repeatable, at 
least as effective as magnetic resonance imaging for diagnosing avulsion injury (30) 
and very unlikely to result in false positive results (31). Fig 2.7 illustrates tomographic 
ultrasound imaging of an intact levator and Fig 2.8, a right complete levator avulsion.   
Fig 2.7: Tomographic ultrasound imaging of an intact puborectalis muscle. Eight axial 
plane slices are set at 2.5mm interslice intervals. The central slice (Slice 4) is placed 
at the plane of minimal hiatal dimensions showing ‘closing’ of the symphysis pubis, 
as identified by arrows. The slice to the left (Slice 3) is set 2.5mm caudad, showing 
the symphysis pubis open, the one to the right (Slice 5) is 2.5mm cranial, with the 
pubic rami ‘closed’ or invisible due to acoustic shadowing. The three central slices 
(Slice 3-5) as represented by the red asterisks are analysed to provide minimal 
criteria for the diagnosis of levator avulsion.  
0 1
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Fig 2.8: Tomographic ultrasound imaging of a right-sided (unilateral) complete levator 
avulsion. The asterisks identify the detachment of the puborectalis muscle from its 
insertion on the right inferior pubic ramus. From Dietz et al, Quantification of major 
morphological abnormalities of the levator ani. Ultrasound Obstet Gynecol 2007; 29: 
329 – 34, with permission. 
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2.3.6 Statistical analysis 
Paper 1: Cystocele recurrence after anterior colporrhaphy with and without 
mesh use.  
Statistical analysis was performed with Minitab V13 (Minitab Inc, State College, PA, 
USA) and SAS V9.3 (Cary CR:SAS Institute Inc, USA). Between group 
comparisons were performed using student’s t-tests for continuous variables and 
chi2 analysis for categorical variables. A p-value of <0.05 was considered to be 
statistically significant. To compare subjective and objective outcomes between the 
two methods of repair, we conducted multiple regression or logistic regressing 
analyses, as appropriate, adjusting for significant potential confounders of 
prolapse recurrence such as age, BMI, previous vaginal delivery, previous vaginal 
repair surgery and length of follow-up.  
Paper 2: Is levator avulsion a predictor of cystocele recurrence following 
anterior vaginal mesh placement 
Statistical analysis was performed using Minitab v13 (Minitab Inc, State College, PA, 
USA). Student’s t-test was performed for continuous variables and chi-square 
analysis for categorical variables; p<0.05 was considered to be statistically significant. 
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Paper 3: A comparison of two different mesh kit systems for anterior 
compartment prolapse repair.  
Statistical analysis was performed using Minitab v13 (Minitab Inc, state college, PA, 
USA) Prism v6.0b (Graph Pad Software, La Jolla, CA, USA) and SAS v9.3 (SAS 
Institute Inc, Cary, NC, USA). Normality was assessed using the D’Agostino & 
Pearson Omnibus normality test. Student t-test was performed for continuous 
variables and chi-square test analysis for categorical variables. A p-value of <0.05 
was considered to be statistically significant. Intraclass correlation statistics (single 
measurement, absolute agreement definition) were used to determine the 
repeatability of sonographic measures of mesh location. To compare subjective and 
objective outcomes between the two mesh kit systems, we conducted multiple 
regression or logistic regression analyses, as appropriate, adjusting for significant 
confounders (p<0.05) identified following univariate analysis.  
Paper 4:  Laparoscopic sacrocolpopexy: how low does the mesh go? 
Statistical analysis was performed with SAS v9.2 (SAS Institute, Cary, NC, USA) and 
SPSS Statistics v.20 (IBM Corp., Armonk, NY,USA). A two-sample t-test was 
performed for continuous variables and chi-square analysis for categorical variables. 
P <0.05 was considered to be statistically significant.  
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Paper 5:  A pilot study on surgical reduction of the levator hiatus with a mesh 
sling – the Puborectalis Sling. 
Statistical analysis was performed using Minitab version 13 (Minitab Inc., State 
College, PA, USA). Student’s t-test was performed for continuous variables and chi2 
analysis for categorical variables. A p-value of <0.05 was considered to be 
statistically significant. Power calculations were not performed due to the pilot nature 
of this study, with no input data available in the literature. 
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2.3.7 Ethics  
 
Paper 1:  
Obtained at all three sites (SWAHS HREC 07-063, Greenslopes Private Hospital 
HREC ref 10-09, Townsville HREC 84/04) 
Paper 2:  
Obtained for all three clinical audits (SWAHS HREC 07-063, Greenslopes Private 
Hospital HREC ref10-09, Townsville HREC 84/04)   
Paper 3:  
Obtained for all three clinical audits (SWAHS HREC 07-063, Townsville HREC 84/04 
and Victoria HREC No. 10310Q) 
Paper 4:  
Obtained from University of Sydney, Human Research Ethics Committee,  
(No 15216) 
Paper 5:  
Nepean Blue Mountain Local Health District Human Research Ethics Committee 
(NBMLHD HREC 10-03). 
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Chapter 3: Cystocele recurrence after anterior 
colporrhaphy with and without mesh use. 
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3.1 Results summary 
This was a retrospective study incorporating the data of two separate clinical audit 
projects. Three hundred and thirty two patients had undergone an anterior 
colporrhaphy with mesh augmentation and 242 had had an anterior colporrhaphy 
only, over a four-year period at three tertiary centres. One hundred and eighty three 
attended surgical audit follow-up at three different time points. PerigeeTM and ProliftTM 
mesh kits systems had been inserted into 100 patients while 83 had had a native 
tissue repair only. The average follow-uS ZDV  yHDUV $ UHFuUUHQW FyVWoFHOH  stage 
2 POPQ) was more commonly found in the anterior colporrhaphy group compared to 
those who had anterior mesh reinforcement (55% vs 33%, p=0.002). After 
adjustment for age, BMI, previous vaginal delivery, previous vaginal repair surgery 
and length of follow-up, the benefit of mesh on prolapse recurrence was still evident, 
but it was seen in women with levator avulsion only.  
There was statistically significant evidence that levator avulsion status modified the 
effect of mesh on the risk of recurrent cystocele (Breslow-Day Chi2 test p=0.01). The 
odds ratio for the effect of mesh on recurrence was 0.97 (95% CI: 0.41 – 2.30) for 
women with no avulsion compared to 0.15 (95% CI: 0.04 – 0.52) for women with 
avulsion.  
Hypothesis 1: ‘Mesh augmentation for anterior compartment prolapse is 
associated with better outcome as compared to traditional 
anterior colporrhaphy’ ZDs FRnIiUPed IRU ZRPen ZiWK OeYDWRU DYXOsiRn RnO\. 
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Cystocele recurrence after anterior colporrhaphy with and without
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1. Introduction
Mesh reinforcement in cystocele repair has become popular in
recent years. Until recently, anterior colporrhaphy was the
standard method of repair. Due to recurrence rates of up to 50%
[1], mesh kits such as PerigeeTM (American Medical Systems,
Minnetonka, MN, USA) or Anterior ProliftTM (Gynecare/Ethicon,
Somerville, NJ, USA) were developed to improve outcomes
following pelvic organ prolapse repair. Whilst there is some
evidence that mesh reinforcement can reduce recurrence rates
[2,3], the use of mesh in pelvic floor reconstructive surgery has
become controversial [4]. This is mainly due to associated
complications such as mesh erosion, chronic pain and dyspareunia
[5].
In view of the rising controversy surrounding mesh use, further
evidence is required to assess the relative weight of complications
of mesh use against the potential benefit of reduced recurrence
rates. A number of authors have investigated risk factors for
recurrence, and younger age [6], a family history of prolapse [7], a
larger prolapse stage [7,8], poor pelvic floor muscle contractility
[9], previous hysterectomy, body mass index (BMI), previous
prolapse surgery, a larger genital hiatus [9], levator avulsion
[7,10,11] and hiatal ballooning (excessive distensibility of the
levator hiatus) [12] all seem to be associated with recurrence.
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Objective: Mesh reinforcement in cystocele repair has become popular in recent years, with some
evidence of reduced recurrence rates. In this retrospective cohort series, we aimed to assess subjective
and objective outcomes, including ultrasound quantification of prolapse, following anterior colpor-
rhaphy with and without mesh use for anterior compartment prolapse.
Study design: We assessed anatomical and functional outcomes of patients after cystocele repair in three
tertiary urogynecology units. Outcome measures included either objective prolapse recurrence (defined
as cystocele ! Stage 2 ICS POP-Q or bladder descent !10 mm below the symphysis pubis on ultrasound)
or subjective prolapse recurrence (defined as symptoms of vaginal lump, bulge or dragging sensation
post-operatively). Comparisons between mesh use and anterior colporrhaphy-only groups were
undertaken, adjusting for potential confounders (age, BMI, vaginal parity, previous prolapse repair,
levator avulsion and length of follow-up) using multiple linear regression and logistic regression
methods.
Results: 183 patients were assessed at an average follow-up of 4 years. Eight-three patients had anterior
colporrhaphy between January 2002 and December 2005, and 100 had an anterior mesh repair between
March 2004 and October 2008. Forty-six (55%) patients in the anterior colporrhaphy group compared to
33 (33%) in the mesh use group were diagnosed with a recurrent cystocele (!stage 2) (p = 0.002). After
adjustment for age, BMI, previous vaginal delivery, previous vaginal repair surgery, and length of follow-
up, the benefit of mesh on prolapse recurrence was principally experienced by women with major
levator trauma.
Conclusions: At a mean of four years’ follow-up, mesh augmentation was associated with reduced
cystocele recurrence, but this effect was limited to patients with levator avulsion.
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Hence, it may be possible to identify patients that may be more
likely to benefit from mesh use.
With this in mind, we aimed to evaluate the long-term
subjective and objective outcomes following anterior colporrha-
phy (AC) with and without mesh use. We also assessed whether
the estimated effect of mesh was modified by the presence of
major trauma to the levator ani muscle (‘avulsion’).
2. Materials and methods
This was a retrospective analysis of data obtained in external
clinical audits of anterior colporrhaphy (AC) with and without
mesh, performed in three tertiary urogynecology centres. All
patients were seen for post-surgical audit appointments which
involved a standardised interview, an International Continence
Society Pelvic Organ Prolapse-Quantification (ICS POP-Q) clinical
examination [13] along with a 4D transperineal ultrasound
examination using Voluson 730 expert or Voluson i systems (GE
Kretztechnik GmBH, Zipf, Austria) with a RAB 8–4 MHz transducer.
They represent a selection of women operated at the three tertiary
centres, as not every patient was able to attend for these external
audits. We have no information on those who declined attendance
and for those who were not contactable.
Outcome measures include either subjective prolapse recur-
rence (defined as symptoms of a vaginal lump, bulge or dragging
sensation) or objective prolapse recurrence (defined as cystoce-
le ! Stage 2 ICS POP-Q) or bladder descent !10 mm below the
symphysis pubis as measured on ultrasound. The latter was
measured on ultrasound on maximum valsalva (Fig. 1) after
bladder emptying, as previously described [14]. A significant
cystocele was defined as bladder descent to 10 mm or more below
the symphysis pubis, a value previously determined on the basis
of receiver-operator characteristic (ROC) statistics, using symp-
toms of prolapse as the outcome measure [15]. Ultrasound volume
data sets were analysed offline on a desktop PC using proprietary
software (4D View v10, GE Kretz Ultrasound, Zipf, Austria).
Volumes obtained at maximum pelvic floor muscle contraction
(or at rest if the patient failed to contract the pelvic floor muscles)
were used to diagnose levator avulsion, using tomographic
ultrasound imaging (TUI), as previously described [16,17]. The
plane of minimal hiatal dimension at maximum pelvic floor
muscle contraction was identified and a tomographic represen-
tation of this volume is represented in the axial plane. Using TUI,
the entire puborectalis muscle is encompassed within eight slices
at 2.5 mm slice intervals. Patients were regarded as avulsion
positive if there was an abnormal puborectalis muscle insertion in
all three central slices (i.e. the slice obtained at the level of the
plane of minimal hiatal dimensions and the two immediately
cranial) (Fig. 2). This method is highly repeatable and agrees well
with the diagnosis of avulsion on magnetic resonance imaging
[18]. Diagnosis of levator avulsion was made by the senior author,
blinded against clinical data.
Patients who had undergone a traditional colporrhaphy were
operated by 7 specialists and their trainees under supervision.
Surgical techniques may therefore vary. Nevertheless all patients
had fascial plication after reflecting the bladder off the vaginal skin,
without paravaginal repair.
Perigee mesh kits were inserted according to manufacturer’s
(AMS, Minnetonka, MN, USA) instructions, with one of the
participating surgeons involved in the development of the mesh
kit system (A.R.). The Perigee mesh kit is inserted after reflecting
the bladder off the vaginal skin using helical needles passing
through the anteromedial and posteromedial aspects of the
obturator foramen and placing the mesh in a tension-free
manner. The Anterior Prolift mesh kits were also inserted
according to manufacturer’s (Gynecare/Ethicon, NJ) instructions
with mesh arms passing through the anterior and posterior
medial aspect of the obturator foramen, using specifically
designed guides and cannulas.
Statistical analysis was undertaken using Minitab version 13
(Minitab Inc., State College, PA, USA) and SAS version 9.3 (Cary CR:
SAS Institute Inc, USA). Between-group comparisons were
performed using t-tests for continuous variables and chi2 tests
for categorical variables. A p-value of <0.05 was considered to be
statistically significant. To compare subjective and objective
outcomes between the two methods of repair, we conducted
multiple regression or logistic regression analyses, as appropriate,
adjusting for significant potential confounders of prolapse
recurrence such as age, BMI, previous vaginal delivery, previous
vaginal repair surgery, and length of follow-up. Ethical approval
for audit projects had been obtained at all three sites (SWAHS
HREC 07-063, Greenslopes Private Hospital HREC ref 10-09,
Townsville HREC 84/04).
3. Results
There were 332 patients who had undergone anterior prolapse
repair with mesh between March 2004 and October 2008, and 242
patients who had an anterior prolapse repair without mesh
between January 2002 and December 2005. One hundred patients
who had AC with mesh (51 Perigee, 49 Anterior Prolift) and 83
patients who had undergone AC without mesh attended the audit
follow-up. These women had responded to an invitation to attend
clinical audit appointments at the participating institutions at
Fig. 1. Identification of bladder descent on maximal valsalva (midsagittal view). The horizontal line represents a reference line drawn against the symphysis pubis. The
vertical line demonstrates the descent of the bladder caudally, below the symphysis pubis. Image on left (A) represents a recurrent cystocele following anterior colporrhaphy
and image on right (B) represents recurrent cystocele following anterior colporrhaphy with mesh. The dotted lines represent an anterior compartment mesh (SP = symphysis
pubis, B = bladder, R = rectum, A = anal canal).
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three different time points. Mesh was used in 100 of these women
(N = 49 ProliftTM, N = 51 PerigeeTM). The mean duration of follow-
up was significantly longer for women who underwent AC without
mesh (4.47 years) compared to those in whom mesh was used
(3.45 years, with p < 0.001 for comparison). Table 1 summarises
the characteristics of each group at the time of the follow-up
assessment. The mean age at assessment was 63 years, the mean
BMI was 28, and the mean vaginal parity was 3. Forty-one (22.4%)
women had previous vaginal repairs, 74 (40.4%) had undergone
previous hysterectomy, 50 (27.3%) had concurrent vaginal
hysterectomy, 20 (10.9%) had a concurrent apical suspension
(13 sacrospinous fixation, 7 sacrohysteropexy), 54 (29.5%) a
placement of suburethral sling, 66 (36.1%) a posterior colporraphy
and 45 (24.6%) a posterior mesh insertion (9 Apogee and 36
Posterior prolift). There were 64 women (35%) with levator
avulsion and of those, 37 were unilateral whilst 27 were bilateral
trauma. The primary endpoint of recurrent cystocele of !stage 2
was observed in 33/100 (33%) in the mesh group and 46/83 (55%)
in the non-mesh group (p = 0.002).
The rate of recurrent cystocele (!Stage 2) for women with no
avulsion in the mesh and non-mesh groups respectively was 22/65
(35%) versus 23/54 (43%), compared to recurrence rates of 11/35
(31%) versus 23/29 (79%) for the mesh and non-mesh groups
among women with an avulsion (p = 0.003). These findings were
confirmed on multivariate regression analysis, adjusting for
potential predictors of prolapse including age, BMI, previous
vaginal delivery, previous vaginal repair surgery, levator avulsion
and length of follow-up (Table 2).
There was statistically significant evidence that levator
avulsion status modified the effect of mesh on the risk of recurrent
cystocele (Breslow-Day Chi2 test p = 0.01). The adjusted odds ratio
Fig. 2. Tomographic ultrasound imaging of the entire puborectalis muscle. The * demonstrates a right-sided levator avulsion. Reproduced, with permission, from Dietz [16].
Table 1
Demographic details of the patients.
Parameter Mesh (n = 100) No mesh (n = 83) p-Value
Age (years) 64.9 65.3 0.807
BMI 28.56 28.36 0.814
Previous vaginal delivery 3.17 (SD 1.49) 3.20 (SD 1.56) 0.878
Previous prolapse surgery 35/100 (35%) 6/83 (7%) <0.001
Levator avulsion 35/100 (35.0%) 29/83 (34.9%) 0.993
Follow-up period (years) 3.45 (SD 0.90) 4.47 (SD 0.95) <0.001
Table 2
Comparison of outcomes following anterior colporrhaphy in patients with and without mesh use. All results shown are from a multivariate regression analysis (y linear
regression, * logistic regression) that adjusts for age, BMI, previous vaginal delivery, previous vaginal repair surgery, levator avulsion as well as length of follow-up.
Status of puborectalis
muscle insertion
Anterior colporrhaphy Mean point Ba !Stage 2 cystocele
recurrence
Mean maximal bladder
descent on valsalvaa (mm)
Avulsion (n = 64) Mesh (n = 35) "1.82 31% (11/35) "0.87
No mesh (n = 29) "0.41 76% (22/29) "16.5
p-Value 95% CI 0.0001y "2.12 to "0.7 0.003* 0.04 to 0.52 <0.0001y 8.92 to 22.28
No avulsion (n = 119) Mesh (n = 65) "1.70 38% (25/65) "1.04
No mesh (n = 54) "1.71 38% (21/54) "1.83
p-Value 95% CI 0.98y "0.54 to 0.55 0.97* 0.41 to 2.39 0.76y "4.31 to 5.91
a Maximal bladder descent is measured against the level of symphysis pubis on valsalva, negative value represents a descent that is below the level of symphysis pubis.
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for the effect of mesh on recurrence was 0.97 (95% CI: 0.41–2.30)
for women with no avulsion, compared to 0.15 (95%CI: 0.04–0.52)
for women with avulsion.
There was a statistically significant difference in women’s
overall satisfaction rate, 82% (82/100) in women with mesh
compared to 65% (54/83) in women with anterior colporrhaphy
only (p = 0.04), while there was no difference in women presenting
with recurrent prolapse symptoms at 20% (20/100) compared to
29% (24/83) in the mesh and non-mesh groups respectively
(p = 0.25).
Statistically significant evidence for avulsion status to modify
the effect of mesh was also found for point Ba and maximum
bladder descent on ultrasound.
4. Comment
In this study, anterior colporraphy with mesh was associated
with a significantly better objective anatomical outcome both
clinically and on ultrasound, at an average follow-up length of 4
years. This is consistent with a recently published randomised
controlled trial by Altman et al. on short-term outcomes [3].
The presence of major levator ani muscle trauma (‘avulsion’)
significantly modified the estimated effect of mesh on recurrence,
point Ba and maximum bladder descent on ultrasound, with the
benefit of mesh augmentation appearing most marked in women
with levator avulsion. This study is the first in the world literature
to demonstrate such an effect, which may potentially be of great
value in clinical practice. Knowledge of predictors of prolapse
recurrence may be important in helping clinicians identify patients
who would benefit the most from mesh reinforcements at the time
of anterior prolapse repair. As mesh use is likely to be associated
with increased complication rates compared to traditional AC,
patient selection seems of paramount importance.
There are a number of factors that can be used to identify
women at higher risk of recurrence: age, prolapse stage, previous
surgery, size of the genital hiatus [9], levator contraction strength
[9], and levator avulsion [7,10,11]. The data presented in this study
reinforce this concept. It may be reasonable to offer mesh to
women who are at an increased risk of recurrence, even as a
primary procedure, rather than to those who are likely to do well
with conventional surgery alone. This may not be technically
difficult, since all the above-quoted risk factors can be ascertained
from interview and clinical examination, including the diagnosis of
avulsion, which can be made on palpation [19,20].
Several potential weaknesses of this study need to be
acknowledged. Firstly, this is a retrospective observational study
using audit data obtained over the course of several years at
several sites by several ultrasound operators. This study design is
subject to a number of potential confounders, not least that of
assessment bias, since the presence of mesh is evident both on
clinical examination and on ultrasound imaging. Unfortunately
this is true for all trials comparing conventional to mesh-
augmented repair, regardless of study design. Another criticism
may be that the large time span may have caused differences
in assessment technique. All personnel, however, were under
the direct supervision of, or trained by, the senior author, and the
audit procedure had been standardised several years prior to the
first data acquisition for this project. All ultrasound parameters
used in the post- processing analysis have been previously
shown to be valid and repeatable [10], and the post-processing
methodology had also been standardised several years prior to
the commencement of this study.
Unfortunately, due to the nature of an external audit and the
heterogeneity of local settings, we were unable to acquire pre-
operative data such as ICS POPQ staging for all patients, and we are
equally unable to provide data on those women who did not
present for these external audits. There may well be a degree of
selection bias, although this bias may apply similarly to both AC
and AC with mesh groups. In addition, the mesh arm of this series
contains patients who received two different kinds of meshes,
adding to the heterogeneity of our data. However, these two mesh
implants (Perigee and Anterior Prolift) both use similar material
and a very similar fixation method (transobturator arms) and have
previously been shown to be comparable on imaging [21].
Overall, the findings from this study may be more generally
applicable than a single-surgeon series examining one single mesh
kit, since most of our patients were operated in public hospitals,
implying the involvement of multiple trainees. In addition,
patients were examined by an external clinician, and any
ultrasound measures were analysed months after the patient
contact, with the operator blinded against all other data.
Moreover, we cannot be sure that women who received mesh
were not systematically different to those who did not, although we
attempted to control this by performing adjusted analyses.
Nonetheless, we acknowledge that this method of control is inferior
to that achieved through random allocation in a controlled trial.
Another potential weakness is that subjective patient outcomes
were not assessed with questionnaires, such as PFDI or PISQ-12. In
a climate where there is an increasing drive towards research on
patient-reported outcomes, recent evidence [2] has concluded that
large RCTs are needed to show differences in patient-reported
outcomes. Comparing surgical interventions with such instru-
ments may be difficult since subjective recurrence is less common
than objective recurrence after prolapse surgery, requiring much
larger trials to achieve sufficient power. In short, questionnaires
are likely to have low power in trials testing surgical interventions
for female pelvic organ prolapse.
In conclusion, at an average follow-up period of 4 years, mesh
augmentation of anterior colporrhaphy was associated with
significantly better objective anatomical outcomes, both clinically
and on sonographic imaging. This positive effect of mesh
augmentation was largely limited to women diagnosed with
avulsion of the puborectalis muscle. Anterior compartment mesh
use in women with intact levator ani may not be beneficial whilst
future surgical intervention trials assessing efficacy of prolapse
mesh use should probably incorporate an assessment for major
levator trauma. Levator avulsion can be used as an entry criterion for
trials given the fact that it is a strong risk factor for prolapse
recurrence following surgical repair. This may substantially enhance
the power of such trials, as recently demonstrated by Svabik et al.
[22] in a randomised controlled trial comparing outcomes following
prolapse repair in women with levator avulsion.
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4.1 Results summary 
In this retrospective study incorporating clinical audit projects, two hundred and nine 
patients were evaluated at an average of 2.2 years (range 3 months – 5.6 years) 
after anterior vaginal mesh repair; 67 Anterior ProliftTM (Gynecare/Ethicon, 
Sommerville, NJ, USA) and 142 PerigeeTM (American Medical Systems, Minnetonka, 
USA). These patients underwent a standardised interview, clinical POPQ 
examination and 4D transperineal ultrasound. Twenty four percent of patients had 
recurrent prolapse symptoms (51/209) whilst 33% (68/209) had recurrent clinical 
cystocele and 26% (54/209) had evidence of a recurrent cystocele on ultrasound. 
Mesh erosion was diagnosed in 11% (22/209) of patients at the time of evaluation. 
Twenty-eight out of 80 (35%) women with levator avulsion had significant 
sonographic cystocele recurrence (odds ratio (OR), 2.24 (95% confidence interval 
(CI), 1.13–4.43)). 
Multivariate logistic regression analysis, adjusting for potential predictors of prolapse 
recurrence, such as age, BMI, vaginal parity, previous prolapse/anti-incontinence 
surgery and length of follow-up as well as for levator avulsion, found that women with 
levator avulsion were more likely to have cystocele recurrence on ultrasound than 
those without avulsion, 34% vs. 20% (OR 2.13, 95% CI: 1.04 – 4.39).  That is, levator 
avulsion doubles the risk of cystocele recurrence despite mesh augmentation in 
anterior colporrhaphy.  
Hypothesis 2: ‘Levator avulsion is a risk factor for prolapse recurrence after 
anterior mesh repair’ was confirmed. 
80 
Ultrasound Obstet Gynecol 2013; 42: 230–234
Published online in Wiley Online Library (wileyonlinelibrary.com). DOI: 10.1002/uog.12433
Is levator avulsion a predictor of cystocele recurrence
following anterior vaginal mesh placement?
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ABSTRACT
Objective Levator avulsion has been shown to be a
predictor of cystocele recurrence following anterior
colporrhaphy. The aim of this study was to determine
if levator avulsion is a risk factor for prolapse recurrence
following anterior colporrhaphy with mesh.
Methods This was a retrospective analysis of data
obtained from three surgical audits for subjective and
objective outcomes following anterior colporrhaphy with
mesh. Recurrence was defined as cystocele ≥ Stage 2 on
the prolapse quantification system of the International
Continence Society; symptoms of vaginal lump/bulge; or
cystocele on ultrasound, defined as maximum bladder
descent to ≥10mm below the symphysis pubis. Levator
avulsion was diagnosed using tomographic ultrasound
imaging.
Results Two hundred and nine patients were followed
up at a mean of 2.2 years (range, 3months to 5.6 years)
after anterior vaginal mesh placement. 24% (51/209)
had recurrent prolapse symptoms, 33% (68/209) clinical
cystocele recurrence ≥ Stage 2, and 26% (54/209) a
recurrent cystocele on ultrasound. Twenty-eight out of
80 (35%) women with levator avulsion had significant
sonographic cystocele recurrence (odds ratio (OR), 2.24
(95% confidence interval (CI), 1.13–4.43)). This finding
was confirmed after adjusting for potential predictors
of prolapse recurrence on multivariate logistic regression
(OR, 2.13 (95% CI, 1.04–4.39); P= 0.04).
Conclusion Levator avulsion doubles the risk of cystocele
recurrence after anterior colporrhaphy with transobtura-
tor mesh. Copyright © 2013 ISUOG. Published by John
Wiley & Sons Ltd.
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INTRODUCTION
Pelvic organ prolapse (POP) is a common condition,
with a reported prevalence ranging from 2 to 48%,
cystocele being the most frequently encountered form of
prolapse1,2. Management is conservative or surgical, the
latter in the form of an anterior colporrhaphy procedure.
Success following traditional anterior colporrhaphy has
been suboptimal, with recurrence rates ranging up to
50%3. Several potential predictors of POP recurrence have
been identified including age, previous prolapse surgery,
preoperative severity of prolapse4, size of genital hiatus5,
levator contraction strength5 and levator avulsion6–9.
Levator avulsion is a form of injury afflicting
15–30% of women following vaginal delivery, defined by
detachment of the puborectalis muscle from the inferior
pubic ramus10–12. It has been shown to be associated
with weaker pelvic floor muscle function and ballooning,
i.e. abnormal distensibility of the levator hiatus, the
largest potential hernial portal in the human body13–15.
It is a risk factor for prolapse development, especially
in the anterior and central compartments15,16. Women
with levator avulsion have been shown to have a two-
to four-fold increased risk of recurrence after anterior
colporrhaphy6–8.
Over the last 8 years, mesh kits have become popular in
POP repair17. The use ofmesh anchored by transobturator
arms is likely to improve both subjective and objective
outcome measures following prolapse repair, especially
in the anterior compartment18–20. However, it is not
clear whether the use of anterior compartment mesh
fully compensates for the recurrence risk conveyed by
levator avulsion18. We therefore undertook this study
to determine whether levator avulsion is a risk factor
for cystocele recurrence following anterior compartment
transobturator mesh placement.
Copyright © 2013 ISUOG. Published by John Wiley & Sons Ltd. ORIGINAL PAPER
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METHODS
This was a retrospective analysis of data obtained
through clinical audits on anterior transobturator mesh
procedures (Perigee™ system, American Medical Systems,
Minnetonka, MN, USA and Anterior Prolift™ system,
Gynecare/Ethicon, Somerville, NJ, USA) performed
at three tertiary urogynecology centers. All patients
had undergone a standardized clinical interview (non-
validated, local), a clinical assessment using the prolapse
quantification system of the International Continence
Society (ICS POP-Q) and a four-dimensional transperineal
ultrasound examination using Voluson 730 Expert or
Voluson i systems (GE Medical Systems, Zipf, Austria)
with RAB 8–4-MHz transducers. Outcome measures
were either subjective prolapse recurrence (defined as
symptomatic of a vaginal lump, bulge or dragging
sensation) or objective prolapse recurrence (defined
as either clinical cystocele ≥ Stage 2/ICS POP-Q or
sonographic recurrence if bladder descent was ≥ 10mm
below the symphysis pubis on ultrasound).
The ultrasound examination was performed by (or
under the immediate supervision of) staff trained by the
senior author for a minimum of 6months, with the
patient in the supine position after bladder emptying,
as described previously21. Ultrasound volumes were
acquired at rest, on maximum Valsalva maneuver and on
pelvic floor muscle contraction. Post-processing analysis
was performed on a desktop computer using proprietary
software (4D View v10, GE Medical Systems). The
assessment for sonographic cystocele was undertaken
by V.W. (after a minimum of 3months’ training in
pelvic floor ultrasound), while the assessment for levator
avulsion was undertaken by the senior author (H.P.D.).
Both were blinded to each other’s findings as well as to all
clinical data. The volume on maximum Valsalva showing
the largest pelvic organ descent was used for analysis of
this parameter. Cystocele recurrence on ultrasound was
rated positive if the most dependent part of the bladder
descended to ≥ 10mm below the inferoposterior margin
of the pubic bone, as described previously21. This cut-off
value was determined on the basis of a receiver–operating
characteristics curve, using symptoms of prolapse as the
outcome measure22.
To assess for levator avulsion, tomographic ultrasound
imaging (TUI) was performed on volumes obtained at
pelvic floor muscle contraction, or at rest if a patient was
unable to contract the pelvic floor muscles. Using TUI,
a set of eight slices was obtained at 2.5-mm intervals,
from 5mm below to 12.5mm above the plane of minimal
hiatal dimensions, as described previously23. This method
has been shown to be valid and repeatable, at least as
effective as magnetic resonance imaging for diagnosing
avulsion injury24, and very unlikely to result in false-
positive results25. Levator avulsion was rated as present
if the plane of minimal dimensions as well as the two
slices cephalad to that plane showed abnormal insertions
of puborectalis muscles to the os pubis (Figure 1).
Ethics approval was obtained for all three clinical
audits (SWAHS HREC 07-063, Greenslopes Private
Hospital HREC ref 10-09, Townsville HREC 84/04).
Statistical analysis was performed using Minitab version
13 (Minitab Inc., State College, PA, USA). Student’s t-test
was performed for continuous variables and chi-square
analysis for categorical variables; P< 0.05 was considered
to be statistically significant.
RESULTS
Three hundred and thirty-two anterior compartment
mesh procedures were performed at the participating
units between 2004 and 2008. Two hundred and nine
of the patients were seen at an average of 2.2 years
(range, 3months to 5.6 years) after anterior vaginal mesh
placement (67 Anterior ProliftTM, 142 PerigeeTM). They
represent only a selection of women operated on at the
three tertiary centers, as not every patient was able to
Figure 1 Pelvic floor ultrasound images showing successful cystocele reduction after anterior mesh placement, seen in midsagittal plane (a),
in a patient with bilateral avulsion ( ) visible on tomographic imaging (b). B, bladder; R, rectal ampulla; S, symphysis pubis; U, uterus.
Copyright © 2013 ISUOG. Published by John Wiley & Sons Ltd. Ultrasound Obstet Gynecol 2013; 42: 230–234.
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attend for these external audits, which were conducted
between 2006 and 2010. Mean age at follow-up was
65 (range, 32–90) years, median vaginal parity was 3
(range, 0–10) and mean body mass index (BMI) was 28.2
(range, 18.0–48.7) kg/m2. One hundred and four patients
(50%) had had a previous hysterectomy and 69 (33%)
a previous vaginal repair. Twenty-eight women (13%)
had undergone a concomitant hysterectomy at the time
of mesh surgery, 26 (12%) a sacrospinous fixation, seven
(3%) a sacrospinous hysteropexy, 67 (32%) a suburethral
sling, 63 (30%) a posterior vaginal repair and 25 (12%)
a posterior compartment mesh placement.
One hundred and seventy-one of the 209 patients (82%)
were satisfied with the outcome of their prolapse repair.
Fifty-one (24%) reported symptoms of recurrence, i.e. the
sensation of a vaginal lump or a dragging sensation. On
clinical examination, mean POP-Q point Ba (the most
distal position on the anterior vaginal wall, with respect
to the hymen) was −1.8 (range, −3 to 3) cm, with 68
patients (33%) having a clinical recurrence of ≥ Stage 2.
Mesh erosion was noted in 22 patients (11%) at the time
of follow-up.
Mean maximum bladder descent was 2.1mm below the
symphysis pubis (range, 21mm above to 38mm below).
Fifty-four (26%) women had a cystocele recurrence on
ultrasound, that is, a bladder descent of ≥ 10mm below
the inferoposterior margin of the pubic bone. Eighty
patients (38%) were diagnosed with levator avulsion on
TUI (bilateral in 41; unilateral in 39 with 25 right-sided,
14 left-sided). In women with levator avulsion, 35%
(28/80) had a recurrent cystocele on ultrasound compared
with 19% (25/129) of women without levator avulsion
(P=0.012; odds ratio (OR), 2.24 (95% confidence
interval (CI), 1.13–4.43)).
All subjective and objective outcome measures favored
the non-avulsion group on univariate analysis. However,
there was no statistically significant difference in women
with levator avulsion compared to those without in
respect to recurrent symptoms (28 vs 21%, P= 0.276),
clinical recurrence (39 vs 29%, P=0.131) or mean
bladder descent on ultrasound measurement (−3.8 vs
−1.0mm, P= 0.142; Table 1). These results were further
confirmed onmultivariate logistic regression analysis after
adjusting for potential predictors of prolapse recurrence,
such as age, BMI, vaginal parity, previous prolapse/anti-
incontinence surgery and length of follow-up as well as for
levator avulsion. Women with levator avulsion remained
more likely to have a cystocele recurrence on ultrasound
than women without avulsion (27/80 (34%) vs 26/129
(20%), P= 0.04, OR 2.13 (95% CI, 1.04–4.39)).
We also undertook subgroup analysis for patients after
Perigee and Prolift insertion; there was no statistically
significant evidence that the association between levator
avulsion status and outcome was modified by mesh type.
DISCUSSION
In this follow-up study of 209 patients seen at an
average of 2.2 years after Perigee or Anterior Prolift mesh
implantation, we found levator avulsion to be a significant
predictor of cystocele recurrence on ultrasonography.
This confirms data obtained after anterior colporrhaphy,
which implies that levator avulsion is a major risk factor
for prolapse recurrence6,7,26. It appears that anterior
compartment mesh implantation does not completely
compensate for the increased recurrence risk associated
with avulsion, although the ORs obtained by us are
lower than those reported for avulsion in traditional
anterior colporrhaphy6,7,26. While it is likely that mesh
reduces recurrence rates, even (or especially) in patients
with avulsion, the prevalence of recurrence symptoms and
signs of prolapse in women with major levator trauma
can still occur in approximately one in three patients18,20.
This is entirely plausible given that avulsion results in
marked distortion of pelvic floor anatomy27,28.
As a result of an increase in hiatal dimensions, the
forces generated by increased intra-abdominal pressure on
anterior compartment fascial supports and, by inference,
also on iatrogenic support structures such as mesh
implants, can be much higher than in women with
a normal pelvic floor15. Since pressure= force/area, i.e.
force per unit area, a given pressure may well generate
twice the force perpendicular to the surface of the hiatus
in someone in whom hiatal area is double that of
another person. In some instances, clinical and ultrasonic
recurrence is associated with findings that can only be
explained by dislodgment of transobturator anchoring
arms (Figure 2). The superior anchoring arms of both
Perigee and Anterior Prolift implants seem particularly
vulnerable in women with avulsion and ballooning of
the hiatus29. Future work in this area should focus
on improving mesh anchoring as well as on means
Table 1 Subjective and objective outcomes after mesh implantation in women with and without levator avulsion (n=209), at a mean
follow-up of 2.2 years
Characteristic Avulsion (n=80) No avulsion (n= 129) P
Recurrent symptoms 22 (28) 27 (21) 0.276
Mean point Ba (cm) −1.58 −1.91 0.092
≥ Stage 2 cystocele 31 (39) 37 (29) 0.131
Mean bladder descent on ultrasound (mm)* −3.8 −1.0 0.142
Significant cystocele on ultrasound 28 (35) 25 (19) 0.012†
Data given as n (%) except where indicated. *The lower the value, the further the cystocele is below the pubic bone. †Odds ratio 2.24 (95%
CI, 1.13–4.43). Ba, Most distal position on anterior vaginal wall, with respect to the hymen.
Copyright © 2013 ISUOG. Published by John Wiley & Sons Ltd. Ultrasound Obstet Gynecol 2013; 42: 230–234.
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Figure 2 Ultrasound images of recurrent cystocele after anterior compartment mesh placement, caused by dislodgment of superior
transobturator arms. The left image shows appearance at rest, the middle one on submaximal Valsalva and the right on maximal Valsalva.
Cranial aspect of mesh (P) is no longer supported and moves freely on Valsalva maneuver. B, bladder; S, symphysis pubis.
to normalize levator morphobiometry to reduce the
occurrence of mesh failure.
Several limitations of this study need to be acknow-
ledged. First, our data were obtained in the context of
three surgical audit projects, reporting the results of four
subspecialist surgeons, and many patients would have
been operated on by trainees. Some may regard this as a
limitation, since operator experience and skills may have
varied widely. However, we regard it as a strength of our
study, as the results should be more generally applicable.
Furthermore, the recurrence rates observed by us are
very similar to those recently reported in a randomized
controlled trial by Altman et al.20 and likely to be
realistic.
Second, we were unable to see all patients operated on
during the inclusion period, implying that some form of
selection bias may have operated in this study. However,
it seems unlikely that any such bias would influence
the relationship between levator avulsion and recurrence,
analysis of which was the main objective of the study.
Third, only sonographic cystocele recurrence was a
significant finding in women with levator avulsion, while
there was no significant difference in symptoms of
recurrence or clinical cystocele recurrence betweenwomen
with and without levator avulsion. Some may consider
subjective and clinical findings to be more valid than
sonographic outcome measures. However, recent studies
have shown that among objective measures of prolapse
recurrence, ultrasound findings of significant cystocele
(that is, bladder descent of ≥ 10mm below the symphysis
pubis) are likely to be the most valid30, and symptoms are
commonly poor outcome measures in surgical trials, as
shown in the study of Altman et al.20. The findings of non-
significance in symptomatology or clinical assessment may
well be due to a lack of power/type II error. At present,
we are conducting a prospective observational study to
validate both ultrasound imaging of pelvic organ prolapse
and clinical prolapse assessment in parallel against
symptoms of prolapse and prolapse bother to investigate
whether ultrasound is indeed better at identifying prolapse
than is clinical ICS POP-Q assessment.
In conclusion, avulsion of the puborectalis muscle, as
diagnosed by TUI, is associated with an increased risk
of cystocele recurrence following transobturator anterior
compartment mesh repair. At an average of 2.2 years
follow-up, the OR for sonographically diagnosed cysto-
cele recurrence in women with levator avulsion is>2.
This implies that transobturator mesh implantation in
such patients does not fully compensate for the effect of
levator trauma on recurrence risk. Future work should
focus on developing more sophisticated models for the
estimation of recurrence risk in the individual patient,
and on reducing recurrence rates in high-risk patients
through surgical innovation.
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5.1 Results summary 
This was a retrospective study utiliVing two clinical audit projects to evaluate two 
different mesh kit systems; the PerigeeTM and the Anterior ElevateTM. Two hundred 
and twenty nine patients with either PerigeeTM (n=138) or Anterior ElevateTM (n=91) 
were seen at a median follow-up of 1.09 years (IQR 0.65 – 2.01). Twenty four 
percent (55/229) were symptomatic of prolapse at time of follow-up, 46% (106/229) 
KDG FOLQLFDO SUoODSVH UHFuUUHQFH 3234  6WDJH  DQG   KDG HYLGHQFH 
of a recurrent cystocele on imaging. All objective results favoured PerigeeTM mesh, 
and this remained highly significantly superior after multivariate analysis (p<0.0001).  
This study showed that apical anchoring with tissue fixation, such as the Anterior 
ElevateTM mesh kit system, did not confer an advantage over the transobturator 
mesh arm fixation method, such as PerigeeTM, in reducing cystocele recurrence.  
Hypothesis 3: ‘Vaginal mesh with apical anchoring to the sacrospinous 
ligaments is associated with improved outcomes compared to mesh implants 
with sidewall fixation’ could not be confirmed. 
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Original Article
A comparison of two different mesh kit systems for anterior
compartment prolapse repair
Vivien WONG,1 Ka Lai SHEK,2 Ajay RANE,3 Joseph LEE,4 Anna ROSAMILIA5 and
Hans Peter DIETZ1
1Department of Obstetrics and Gynaecology, Sydney Medical School Nepean, Penrith, 2Department of Obstetrics and Gynaecology,
University of Western Sydney, Liverpool, 3Department of Obstetrics and Gynaecology, James Cook University, Townsville, Queensland,
4Pelvic Floor Clinic, Monash Moorabbin, Bentleigh East, and 5Department of Obstetrics and Gynaecology, Monash University, Malvern,
Victoria, Australia
Background and Aim: Mesh reinforcement is considered an effective method for anterior compartment prolapse repair.
Two common methods of mesh reinforcement involve either transobturator ﬁxation (eg PerigeeTM) or lateral and apical
anchoring (eg Anterior ElevateTM). The aim of this study was to assess subjective and objective outcomes after Anterior
Elevate and Perigee mesh kit surgery.
Materials and Methods: This was a surgical audit of patients after anterior colporrhaphy (AC) with mesh reinforcement,
undertaken at three tertiary urogynaecological centres. All patients were assessed for prolapse recurrence, which was
deﬁned as either (i) symptoms of prolapse (vaginal lump/dragging), (ii) ICS POPQ ≥ Stage 2, or (iii) bladder descent
≥10 mm below the symphysis pubis on transperineal ultrasound. Mesh co-ordinates and organ descent on Valsalva were
determined relative to the inferior symphyseal margin.
Results: Two hundred and twenty-nine patients with anterior compartment mesh (138 Perigee, 91 Elevate) were assessed
at a median follow-up of 1.09 years (IQR 0.65–2.01). On assessment, 24% (n = 55) had symptoms of prolapse
recurrence, 46% (n = 106) had a clinical recurrence, and 41% (n = 95) a recurrent cystocele sonographically. All objective
results favoured the Perigee group. The superiority of the Perigee kit remained highly signiﬁcant (P < 0.0001 for all
clinical and ultrasound measures of prolapse recurrence) on multivariate analysis.
Conclusions: This retrospective analysis suggests that apical anchoring such as Anterior Elevate mesh system does not
necessarily confer an advantage over the original transobturator mesh ﬁxation technique for anterior compartment
reconstruction.
Key words: 3D ultrasound, anterior colporrhaphy, cystocele, mesh, pelvic organ prolapse, recurrence.
Introduction
Pelvic organ prolapse (POP) is a debilitating condition
afﬂicting a substantial proportion of the female population1
and accounts for approximately 1/3 of gynaecological
consults in USA in women over the age of 50.2 In Western
Australia, the estimated lifetime risk of a patient requiring
reconstructive surgery is as high as 19%.3 Amongst the
different types of POP, cystocele is the most common4
and the most challenging to repair, with recurrence rates
of about 30–50% following traditional native tissue
reconstruction.5,6
In the last nine years, anterior compartment mesh kits
have become popular due to a higher anatomical success
rate, when compared with native tissue repair.7 Mesh kits
such as the PerigeeTM system (American Medical Systems,
Minnetonka, MN, USA) use a polypropylene mesh that is
anchored to the pelvic sidewall with strip-like mesh arms
that perforate through the obturator foramen. Safety and
efﬁcacy of the PerigeeTM system have been documented
with recent ﬁve-year data.8 However, failure (that is, pull-
through) of those anchoring arms is not uncommon.9
Due to increasing emphasis on the importance of apical
support for the anterior compartment,10 mesh kit systems
such as the Anterior ElevateTM (American Medical
Systems) were introduced. In order to provide sacros-
pinous ligament (SSL) anchorage and to avoid blind
transobturator trocar needle passes, the Anterior ElevateTM
mesh kit system utilises tissue anchors to the arcus
tendineus fascia pelvis (ATFP) and the SSL rather than the
transobturator arms. It has been shown to be safe and
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effective in treating anterior compartment prolapse in the
medium term.11
The purpose of our study was to assess subjective and
objective anatomical outcomes between the apically
anchored Anterior Elevate and the transobturator Perigee
mesh kit systems.
Materials and Methods
This is an observational study using data obtained in
one internal and two external surgical audits of anterior
compartment mesh conducted at three tertiary urogy-
naecological centres. The external audit follow-up
assessments were conducted by a team of investigators
from a unit not involved in the index surgery or ongoing
patient care, over a one-week period. Women who had a
Perigee or Anterior Elevate mesh repair were invited to
attend an audit appointment at least three months after the
procedure. All participants underwent a standardised
interview, inquiring on urinary, bowel and sexual function.
Women were also asked whether they were ‘satisﬁed with
outcome of surgery’ and whether they felt ‘cured,
improved, same or worse’. The participants also underwent
an ICS Pelvic Organ Prolapse quantiﬁcation (POP-Q)12
clinical assessment and a 4D transperineal ultrasound
imaging using GE Kretz Voluson 730 expert or Voluson-I
systems with RAB 4-8 MHz transducer (GE Medical
Systems, Zipf, Austria).
Ultrasound volumes were acquired supine after bladder
emptying, as previously described.13 Volume acquisition
was performed at rest, on maximal Valsalva and on pelvic
ﬂoor muscle contraction (PFMC). Postprocessing analysis
of these datasets was undertaken, several months after
data collection, with proprietary software 4D view (version
7.0, 10.0; GE Kretz Ultrasound, Zipf, Austria), blinded
against all clinical data.
The status of the puborectalis muscle was assessed
using volume acquired on PFMC or at rest if the woman
could not contract the pelvic ﬂoor. Using tomographic
ultrasound imaging (TUI), the entire puborectalis muscle
complex is imaged at 2.5-mm slice intervals. The plane of
minimal hiatal dimensions, ie, an axial plane incorporating
the shortest distance between posterior symphyseal margin
and anterior border of the puborectalis muscle, is selected
as reference plane. A woman was rated as positive for
levator avulsion if the plane of minimal hiatal dimensions,
as well as slices 2.5- and 5-mm cranial to that plane, all
showed an abnormal insertion.14
Levator hiatal area was measured using rendered images
as previously described.15 Anterior compartment mesh
was visualised as a hyperechoic linear structure in the mid-
sagittal plane. Lowest mesh position was ascertained on
maximal Valsalva with the most caudal aspect of the mesh
plotted against a reference line drawn from the inferior
margin of the symphysis pubis, as seen following an
Anterior Elevate mesh (Fig. 1) and a Perigee mesh
(Fig. 2). Due to poor visualisation of the cranial end of
the mesh in most cases, cranial mesh co-ordinate
measurements were not performed. A test–retest series
(n = 50) on mesh position was performed by VW and
KLS.
Women were evaluated for subjective (ie symptoms of
vaginal bulge/lump) and objective prolapse recurrence.
The latter was deﬁned either clinically (point Ba ≥ !1) or
sonographically (most dependent part of the bladder
≥10 mm below the inferoposterior margin of the sym-
physis pubis) as previously described.16 The deﬁnition of
signiﬁcant cystocele on ultrasound was previously
determined on the basis of receiver operator characteristic
curve, using symptoms of prolapse as outcome measure.17
Statistical analysis was undertaken using Minitab
version 13 (Minitab Inc., State College, PA, USA), Prism
v6.0b (GraphPad Software, La Jolla, CA, USA) and SAS
version 9.3 (SAS Institute Inc., Cary, NC, USA).
Normality was assessed using the D’Agostino & Pearson
Omnibus normality test. Student’s t-test was performed
for continuous variables and chi-square test analysis for
categorical variables. A P-value of <0.05 was considered to
be statistically signiﬁcant. Intraclass correlation statistics
(single measurement, absolute agreement deﬁnition) were
used to determine the repeatability of sonographic
measures of mesh location. To compare subjective and
(a) (b)
Figure 1 Mesh imaging on translabial ultrasound at rest (a) and on Valsalva (b). The Anterior Elevate mesh is identiﬁed by the dotted
line. Mesh position is measured against the reference of the inferoposterior symphyseal margin. The vertical lines show the postions of
cranial and caudal mesh aspects. B, bladder; R, rectum; S, symphysis pubis; U, urethra.
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objective outcomes between the two mesh kit systems, we
conducted multiple regression or logistic regression
analyses, as appropriate, adjusting for signiﬁcant con-
founders (P < 0.05) identiﬁed following univariate
analysis. Ethics approval had been obtained for all three
clinical audits (SWAHS HREC 07-063, Townsville
HREC 84/04 and Victoria HREC No. 10310Q).
Results
Three hundred and thirty-eight women had an anterior
compartment mesh between September 2004 to August
2011 (202 Perigee mesh between September 2004–
February 2011, 136 Anterior Elevate mesh between July
2009–August 2011) at participating units and were invited
to participate. Of these, 229 women (138 Perigee and 91
Anterior Elevate) attended (68% of Perigees, 67% of
Anterior Elevate cases). The median follow-up was
1.09 years (IQR 0.65–2.01), median age was 66 years
(IQR 60–72), median BMI was 27.4 (IQR 24.3–30.1) and
median vaginal parity was 3 (IQR 2–4). Demographic
data and concomitant procedures of the two groups are
shown in Tables 1 and 2.
All women had at least a Stage 2 anterior vaginal
prolapse (point Ba ≥ !1) prior to surgery; however, due
to the retrospective design of the study, we were only able
to retrieve pre-operative POPQ data in 158 women. Of
these 158 women, 110 had POP Stage 3 or 4 (83 anterior
compartment, 14 apical compartment and 13 posterior
compartment). The mean point Ba pre-operatively was +1
and mean point C was !4.
One hundred and eighty-nine women (83%) were
satisﬁed with their procedure (82% in Perigee, 84% in
Anterior Elevate groups), and 85 (37%; 50 (36%) in
Perigee, and 35 (38%) in Anterior Elevate groups)
considered themselves cured. Fifty-ﬁve women (24%)
were symptomatic of prolapse recurrence (37 in Perigee,
and 18 in Anterior Elevate groups). On assessment, 46%
(n = 106) had a clinical recurrence (ICS POPQ ≥ Stage
2) and 41% (n = 95) a recurrent cystocele on USA. Mean
point Ba was !1.5, and mean bladder descent on USA
was 7 mm below the symphysis pubis (SD 13). Levator
avulsion was found in 99 women (43%); 46 unilateral and
53 bilateral. The mean hiatal area was 34.1 cm2 (SD 8.8),
which is deﬁned as moderate hiatal ballooning.18
Table 3 shows a comparison of the subjective and
objective outcomes of the two groups. On multivariate
analysis of mesh type adjusting for potential confounders
of prolapse recurrence, including follow-up time,
concomitant sacrospinous ﬁxation and posterior mesh
surgery, the difference in outcomes between Anterior
Elevate and Perigee remained highly signiﬁcant
(P < 0.0001 for clinical and ultrasound measures of
prolapse recurrence). Anterior Elevate meshes seemed to
descend to a substantially lower position on Valsalva.
However, there was no signiﬁcant difference between the
groups in recurrent prolapse symptoms.
A subanalysis of women for whom pre-operative Ba and
C measurements were available (n = 158) failed to show
any predictive value of pre-operative prolapse staging and
no confounding effect on groupwise comparisons.
There were 19/229 women (8%) with mesh exposure at
the time of the surgical audit assessments, with 12 seen in
the Perigee and seven in the Anterior Elevate groups
(P = 0.845). Seventeen out of two hundred and twenty-
nine women (7.4%) complained of pelvic pain and 20/158
who were sexually active experienced dyspareunia
(12.7%). There were no differences in complaints of
chronic pelvic pain between Anterior Elevate and Perigee
groups (P = 0.38).
Discussion
Female POP is a common condition, and surgical
correction remains a major challenge especially in the
anterior compartment. Over the last ten years, there has
been substantial change in available surgical techniques,
largely due to the development of modern prolapse mesh
kits. Mesh use in anterior compartment repair has been
shown to be superior to traditional repair in normalising
anatomy;7 however, there are substantial disadvantages
due to novel and sometimes major complications.19
(a) (b)
Figure 2 Mesh imaging on translabial ultrasound at rest (a) and on Valsalva (b). The Perigee mesh is identiﬁed by the dotted line. A
hyperechoic mid-urethral sling can also be seen in this image. B, bladder; R, rectum; S, symphysis pubis. Reproduced with permission
from Shek9.
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In this current study, we tested two commonly used
mesh products employing different methods of ﬁxation.
We audited subjective and objective outcomes in 229
women at a mean follow-up of over one year. Due to the
timing of the respective audits, Perigee cases may be
considered a ‘historical control’ group.
The majority of women (83%) were satisﬁed with
the outcome of their procedure. However, objective
anatomical results were less optimal, with over 40% of
women showing signs of signiﬁcant cystocele recurrence.
The Anterior Elevate mesh procedure appears to be
inferior in achieving successful anatomical reconstruction,
with all comparisons of objective outcomes favouring the
Perigee group. This is surprising and may be considered
counter-intuitive, given that apical support has been
assumed to be a crucial contributor to anterior
compartment failure.10,20 Due to this perception, there has
been a gradual move towards the incorporation of
sacrospinous suspension at the time of cystocele repair.
However, as shown in the Anterior Elevate group of this
study, superior apical support does not necessarily
translate to superior anterior compartment support. Only
24 women in the Perigee group had a concurrent apical
suspension compared with all in the Anterior Elevate
group, but it seems that Perigee provided better mid-
vaginal or ‘Level II’ support. This was despite longer
average follow-up in the Perigee group.
The inferior performance of Anterior Elevate may
plausibly be explained by the mechanical integrity of the
different anchoring structures, or it may be due to the
inadvertent placement of anchors to structures other than
the obturator internus or sacrospinous ligament.
Furthermore, it is plausible that the self-ﬁxating anchors of
Anterior Elevate may not provide sufﬁcient load-bearing
capability and Level II support compared with the
transobturator arms of Perigee mesh kits which employ a
‘velcro-like’ effect along the entire path of mesh arm
implantation. However, the transobturator anchoring
employed by the Perigee system is by no means perfect as
shown again in this series, with 1/3 of women having
objective evidence of recurrence.
To our knowledge, this is the ﬁrst comparative study of
outcomes between two modalities of anterior compartment
mesh anchoring. However, several limitations of our study
need to be acknowledged. Firstly, the study involved
analysis of data obtained in two external audit projects that
were performed by a visiting team within one working week
in each series. Whilst we attempted to control for potential
confounders using multivariate analysis, there may be other
unknown variables we have not adjusted for, which would
have been controlled for in a randomised controlled trial.
Secondly, due to the vast geographical distances that some
women had to travel, many were unable to return for
follow-up during the audit weeks, implying potential
selection bias. However, we were able to assess almost 70%
of women operated on during the inclusion period.
As this study was an audit of three subspecialist
urogynaecology teaching centres, results are likely to be
Table 2 Concomitant procedures performed between the Perigee
and Anterior Elevate groups
Concomitant procedures
Perigee
(N = 138)
Anterior
Elevate
(N = 91) P value
Hysterectomy 19 7 0.156*
Sacrospinous ﬁxation 20 1 0.001*
Sacrohysteropexy 4 0 0.101*
Posterior repair 50 40 0.242*
Posterior mesh repair
(Apogee/Posterior elevate)
24 7 0.001*
Mid-urethral sling 32 26 0.359*
*Chi-square test analysis.
Table 1 Demographics and pre-operative data amongst the
Perigee and the Anterior Elevate women
Parameters Perigee (N = 138)
Anterior Elevate
(N = 91) P-value
Follow-up
(years)
(median,
(IQR))
1.38 (0.86–3.17) 0.77 (0.45–1.21) <0.0001*
Age (years)
(median,
(IQR))
65.6 (56.1–72.7) 66.3 (62.1–71.2) 0.243*
BMI (kg/m2)
(median,
(IQR))
27.6 (24.8–30.4) 27.0 (23.8–30.0) 0.386*
Vaginal
parity
(median,
(IQR))
3 (2–4) 3 (2–3) 0.305*
Previous
vaginal
prolapse
repair
53 41 0.317†
Previous
hysterectomy
69 47 0.807†
Previous
incontinence
procedure
6 5 0.691†
Pre-operative POP-Q
Ba (mean,
SD)
+1.4 (1.9) +1.6 (1.1) 0.576‡
C (mean,
SD)
!3.2 (4.1) !3.9 (3.6) 0.289‡
Levator hiatal
area (mean,
SD)
34.6 cm2 (9.15) 33.3 cm2 (8.21) 0.269‡
Levator
avulsion
59 40 0.857†
*Mann–Whitney U-test.
†Chi-suare test analysis.
‡Student’s t-test.
POP-Q, Pelvic Organ Prolapse quantiﬁcation.
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representative of a wide range of skill levels and surgical
techniques amongst the participating clinicians/surgeons.
Mesh tension adjustment and technique of placement may
vary amongst surgeons and over time, and it is impossible
to assess the impact of individual technique in this data
set. Some may consider the likely variations in technique a
disadvantage. We would argue that our results are likely to
be more representative of general gynaecological practice.
Furthermore, we may have inadvertently compared older
polypropylene mesh quality with newer mesh qualities and
performance. However, any potential change in mesh
quality would not seem to be of advantage, given the
results of this study.
Thirdly, we did not utilise validated questionnaires to
assess patient reported outcomes. However, questionnaires
are notoriously insensitive to change after prolapse
surgery, and the symptom of the ‘feeling of a vaginal
lump/bulge’ has been shown to strongly correlate with
anatomical prolapse.21
In this study, anatomical cure rates are inferior to those
previously reported for both mesh systems11,22,23
suggesting that perhaps our deﬁnition of anatomical success
may be too strict. It has recently been proposed that
cystocele recurrence should be deﬁned as Ba ≥ 0.24 Own
data25 suggest that point Ba = !1 and Ba = 0 are equally
valid in deﬁning ‘signiﬁcant prolapse’ as Ba = !0.5
performs best when analysed as a predictor of prolapse
symptoms with receiver operator characteristics statistics.
At any rate, any re-deﬁnition of anatomical success would
have no bearing on the main ﬁnding of this study, ie, the
superiority of anterior compartment anatomical outcomes
after Perigee mesh.
As mentioned above, our results appear to contradict
other series published as regards anatomical efﬁcacy of
mesh kits, and this is true for both mesh systems. Moore
et al.11 have shown an objective cystocele cure rate of over
90% (≤stage 1) at a mean follow-up of 13.4 months, and
Gauruder-Burmester et al.26 found similar success rates
after Perigee mesh kit systems. However, internal audit
data invariably produce higher success rates than RCTs or
external audits, and absolute numbers are of limited
relevance for the main aim of our study which was to
compare subjective and objective anatomical outcomes of
the two techniques.
Anatomical success is of course not the only factor to
consider in comparing surgical techniques. Some
proponents of the single-incision mesh kits believe that
avoiding lateral graft penetration of the pelvic side wall
may result in less chronic postoperative pain; however, in
our study, the incidence of chronic pain after mesh
insertion did not appear to be signiﬁcantly different
between the groups.
In conclusion, in this retrospective analysis of data
obtained in audit projects at three tertiary urogynaecological
centres, the apical anchoring of the Anterior Elevate mesh
system did not confer any advantage over the transobturator
mesh ﬁxation technique for anterior compartment
reconstruction employed by the Perigee system. This study
will facilitate the planning of future randomised controlled
trials by allowing power calculations for both subjective and
objective outcome measures.
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6.1 Results summary 
A surgical audit of 97 patients at a mean follow-up of 3.01 years (range 0.13 – 
6.87yrs) after laparoscopic sacrocolpopexy found clinical prolapse recurrence in 62% 
(60/97) in the anterior compartment and 44% (43/97) in the posterior compartment. 
The apical compartment remained very well elevated with no clinical recurrence. 
Mesh could be visualised on ultrasound in 62% (60/97) patients in the anterior 
compartment. Using the formula ¥ >;YDOVDOYD-Xrest]2 + [Yvalsalva – Yrest]2), mesh 
mobility was measured at rest and on Valsalva. Both the mesh position and mobility 
on Valsalva were significantly associated with recurrent cystocele on clinical and on 
ultrasound assessment (all p<0.01).  
This study found that cystocele recurrence was not uncommon after laparoscopic 
sacrocolpopexy. Support of the mid-vagina appears to be crucial. For every mm that 
the mesh was located further from the bladder neck on Valsalva, the likelihood of 
cystocele recurrence increased by 6 – 7%.  
Hypothesis 4: ‘Abdominally placed mesh for apical or uterine prolapse is 
effective for anterior compartment support’ could not be confirmed.  
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ABSTRACT
Objective Laparoscopic sacrocolpopexy is becoming an
increasingly popular surgical approach for repair of
apical vaginal prolapse. The aim of this study was
to document the postoperative anterior mesh position
after laparoscopic sacrocolpopexy and to investigate
the relationship between mesh location and anterior
compartment support.
Methods This was an external audit of patients who
underwent laparoscopic sacrocolpopexy for apical pro-
lapse≥ Stage 2 or advanced prolapse≥ Stage 3, between
January 2005 and June 2012. All patients were
assessed with a standardized interview, clinical assess-
ment using the International Continence Society Pelvic
Organ Prolapse quantification and four-dimensional
transperineal ultrasound to evaluate pelvic organ sup-
port and mesh location. Mesh position was assessed
with respect to the symphysis pubis whilst dis-
tal mesh mobility was assessed using the formula√
[(XValsalva – Xrest)2+ (YValsalva – Yrest)2], where X is the
horizontal distance and Y is the vertical distance between
the mesh and the inferior symphyseal margin, measured
at rest and on Valsalva.
Results Ninety-seven women were assessed at a mean
follow-up of 3.01 (range, 0.13–6.87) years after laparo-
scopic sacrocolpopexy, 88% (85/97) of whom considered
themselves to be cured or improved, and none had
required reoperation. On clinical examination, prolapse
recurrence in the apical compartment was not diagnosed
in any patient; however, 60 (62%) had recurrence in the
anterior compartment and 43 (44%) in the posterior
compartment. On ultrasound examination, mesh was
visualized in the anterior compartment in 60 patients.
Both mesh position and mobility on Valsalva were sig-
nificantly associated with recurrent cystocele on clinical
and on ultrasound assessment (all P<0.01). For every
mm that the mesh was located further from the bladder
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neck on Valsalva, the likelihood of cystocele recurrence
increased by 6–7%.
Conclusion At an average follow-up of 3 years, laparo-
scopic sacrocolpopexy was highly effective for apical
support; however, cystocele recurrence was common
despite an emphasis on anterior mesh extension. Pro-
lapse recurrence seemed to be related to mesh position
and mobility, suggesting that the lower the mesh is from
the bladder neck, the lower the likelihood of anterior com-
partment prolapse recurrence. Copyright© 2016 ISUOG.
Published by John Wiley & Sons Ltd.
INTRODUCTION
Laparoscopic sacrocolpopexy has become accepted
widely as an alternative to abdominal sacrocolpopexy
for treatment of prolapse, and surgical outcomes seem
to be comparable1–3. Recent evidence has shown that
laparoscopic sacrocolpopexy is associated with a shorter
length of hospital stay and a quicker return to normal
activity, with less morbidity4. Given the recent controver-
sies over using mesh in vaginal prolapse repair, there is
a palpable shift in practice away from inserting mesh in
the vagina to placing it abdominally instead. Mesh placed
abdominally appears to give fewer incidences of mesh
erosions, dyspareunia and chronic pelvic pain5.
The primary goal with sacrocolpopexy is to provide
apical support for women with a predominantly vault
or uterine prolapse. During the procedure, a ‘Y-shaped’
polypropylene mesh is attached from the anterior
longitudinal ligament of the sacral promontory to the
anterior and posterior vaginal vault. This provides robust
prolapse repair, with high success rates of 78–100%,
especially for the apical compartment. However, it is less
successful for the anterior and posterior compartments6.
Prolapse recurrence in the anterior and posterior
compartments may be due to a more challenging
caudad dissection during sacrocolpopexy, which is often
Copyright © 2016 ISUOG. Published by John Wiley & Sons Ltd. ORIGINAL PAPER
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limited by poor tissue-plane separation and bleeding.
Consequently, it is not surprising that the majority of
failures following sacrocolpopexy occur in repair of
the anterior compartment2. Fortuitously, mesh appears
highly echogenic on ultrasound, which permits convenient
assessment of its location and the functional impact it has
on pelvic organ support following insertion7. Therefore,
the aim of this study was to document the postoperative
anterior mesh position after laparoscopic sacrocolpopexy
and to investigate the relationship between mesh location
and anterior compartment support.
METHODS
This was an external surgical audit of patients who
underwent a laparoscopic sacrocolpopexy procedure by
an experienced endoscopic surgeon at a tertiary center,
over a 7-year period between January 2005 and June
2012. Laparoscopic sacrocolpopexy was performed in all
patients who had apical prolapse≥ Stage 2 or advanced
prolapse≥ Stage 3 in the anterior compartment.
The laparoscopic procedure was performed with dissec-
tion of the peritoneum overlying the vault and reflection of
the bladder off the vagina anteriorly and the rectum poste-
riorly. Dissection was then continued pararectally, using a
combination of blunt- and thermo-dissection towards the
anterior portion of the levator ani muscle bilaterally. The
peritoneum was then incised over the sacral promontory,
exposing the anterior longitudinal ligament of the sacrum,
and the incision was extended along the right lateral pelvic
side-wall towards the vault. Once the dissection was con-
sidered satisfactory, anterior and posterior polypropylene
meshes (Gynecare Gynemesh™, Ethicon US, LLC, Cincin-
nati, OH, USA) were introduced into the abdomen. The
anterior mesh was secured onto the anterior vaginal wall
using six 2.0 dissolvable polydioxanone sutures and poste-
riorly the mesh was placed onto the levator muscle using
two 5-mm tackers (ProTack™, Tyco Healthcare, Nor-
walk, CT, USA) bilaterally. The meshes were then sutured
together, away from the vault. At the sacral promontory,
the mesh was triple-folded and anchored without ten-
sion onto the sacral promontory using the ProTack and
reperitonealized. If deemed necessary, upon completion
of the sacrocolpopexy, a concomitant paravaginal repair,
a modified Tanagho technique8 for colposuspension, or
anterior/posterior colporrhaphy was performed.
All patients were invited to return for an audit
assessment by an independent clinician who had not been
involved in the index surgery or immediate postoperative
care. All patients underwent a standardized interview, a
clinical assessment by International Continence Society
(ICS) Pelvic Organ Prolapse quantification (POP-Q)9 and
a four-dimensional (4D) transperineal ultrasound, using
either a GE Voluson 730 Expert system or a Voluson S6
(RAB 8–4 transducer) system (GE Medical Systems,
Zipf, Austria). Patients were evaluated subjectively (i.e.
symptoms of vaginal bulge or lump) and objectively
(clinical examination and ultrasound assessment) for
prolapse recurrence. Patients were also evaluated for
satisfaction with their surgical outcome by answering
‘yes’, ‘no’ or ‘not sure’ to the question ‘are you satisfied
with the procedure?’
Significant prolapse recurrence on clinical examination
was defined as the most distal point of either the anterior,
apical or posterior walls ≥−1 cm from the hymenal
remnant (i.e. ICS POP-Q≥ Stage 2). Prolapse recurrence
on ultrasound was diagnosed using previously defined
cut-off values: 10mm below the symphysis pubis for
significant cystocele, 15mm below the symphysis pubis
for significant rectocele and at the level of symphysis pubis
for significant uterine/vault prolapse10.
Ultrasound volumes were acquired by V.W. and
R.G.R., with the patient in the supine position after blad-
der emptying, using techniques described previously11.
Volumes obtained at rest, on maximal Valsalva and on
maximal pelvic floor muscle contraction (PFMC) were
selected for analysis. Post-processing analysis of these
datasets was undertaken with the proprietary software
4D View (versions 7.0 and 10.0; GE Medical Systems) by
V.W., blinded against all clinical data.
The status of the puborectalis muscle was assessed
using tomographic ultrasound imaging, as described
previously12. Validated minimal criteria for the diagnosis
of puborectalis muscle/levator avulsion12 were used.
Briefly, a patient was rated as having a levator avulsion
if the plane of minimal hiatal dimensions and slices 2.5
and 5mm cranial to that plane all showed an abnormal
insertion, with a levator–urethra gap of ≥ 2.5mm13.
Levator hiatal dimensions (cm2) were measured using
rendered images14.
Meshwas identified on ultrasound as a highly echogenic
structure in all three orthogonal planes (mid-sagittal,
coronal and axial; Figure 1), at rest and on maximum
Valsalva. Lowest mesh position was identified in the
mid-sagittal plane on maximum Valsalva, with the most
caudal aspect of the mesh plotted against a reference line
drawn from the inferoposterior margin of the symphysis
pubis (Figure 2). Unfortunately, due to poor visualization
of the cranial end of the mesh on Valsalva, recording of
cranial mesh co-ordinate measurements was not possible.
Distal mesh mobility was assessed using the formula√
[(XValsalva – Xrest)2+ (YValsalva – Yrest)2], from rest to
maximum Valsalva, where X is the horizontal distance
between mesh and inferior symphyseal margin and Y
is the vertical distance between the mesh and inferior
symphyseal margin. Where mesh was not visible along
the anterior vaginal wall, the location of the vaginal apex
was used to measure co-ordinates. The distance of the
mesh from its lowest position to the bladder neck was
also determined at rest and on maximum Valsalva.
Statistical analysis was performed with SAS v.9.2
(SAS Institute, Cary, NC, USA) and SPSS Statistics v.20
(IBM Corp., Armonk, NY, USA). A two-sample t-test
was performed for continuous variables and chi-square
analysis for categorical variables. P< 0.05 was considered
to be statistically significant. This study was approved
by the University of Sydney, Human Research Ethics
Committee (protocol 15216).
Copyright © 2016 ISUOG. Published by John Wiley & Sons Ltd. Ultrasound Obstet Gynecol 2017; 49: 404–408.
97
406 Wong et al.
Figure 1 Mesh location (arrows) on four-dimensional transperineal ultrasound in mid-sagittal (a), coronal (b) and axial (c) planes on
maximum Valsalva.
Figure 2 Measurement of mesh mobility by four-dimensional transperineal ultrasound at rest (a) and on Valsalva (b), using the formula:√
[(XValsalva – Xrest)2+ (YValsalva – Yrest)2], where X is horizontal distance and Y is vertical distance of mesh from symphysis pubis.
RESULTS
Between January 2005 and June 2012, 231 patients
underwent laparoscopic prolapse surgery. Of all patients
who were invited to return for an audit assessment, 114
(49%) were seen at a mean follow-up of 3.01 (range,
0.13–6.87) years. Three patients were excluded as they
had undergone laparoscopic sacrohysteropexy. Fourteen
ultrasound volumes were excluded due to a technical error
with volume acquisition, leaving 97 available for analysis.
All subsequent results refer to this dataset. Mean age was
61 (range, 40–77) years, mean body mass index was 26.9
(range, 18.6–39.5) kg/m2 and mean parity was 3 (range,
0–8).
Twenty-six patients had previous vaginal hysterec-
tomy with or without pelvic organ prolapse repair, and
five had a previous anti-incontinence procedure, pre-
dominantly colposuspensions. Preoperatively, all patients
who underwent surgery had prolapse≥ Stage 2: 64 had
anterior compartment prolapse≥ Stage 3, 84 had api-
cal compartment prolapse≥ Stage 2 and 32 had posterior
compartment prolapse≥ Stage 3. Concurrent procedures
performed were 67 total laparoscopic hysterectomies, one
subtotal hysterectomy, 49 paravaginal repairs, 23 laparo-
scopic colposuspensions and 34 posterior colporrhaphies
and perineorraphies. There were no conversions to an
abdominal sacrocolpopexy, nor were there any rectal or
bladder injuries.
Eighty-three patients were satisfied with their procedure
and 85 (88%) considered themselves cured or improved
overall. Recurrent prolapse symptoms were reported in
30 (32%) women. Clinical prolapse recurrence (ICS
POP-Q≥ Stage 2) was diagnosed in 80 patients, including
60 cases affecting the anterior compartment and 43
affecting the posterior compartment; however, recurrence
in the apical compartment was not diagnosed in any
patient. Nine patients had de-novo development of
anterior compartment prolapse and 17 of posterior
compartment prolapse. No patient had undergone a
reoperation for prolapse in the follow-up interval. The
tacks in the levatormuscle were palpable in 20 patients, 16
(17%) of whom complained of tenderness upon palpation
and 12 (12%) had symptomatic dyspareunia.
Ultrasound volume analysis was performed approx-
imately 6months after data acquisition. Eighty-one
patients had sonographic prolapse recurrence: 52 in the
anterior compartment, 64 in the posterior compartment
and 11 in the apical compartment. Mean± SD bladder
neck descent was 24.0± 4.2mm, mean cystocele descent
was 10.6 (range, 18.7 to −52.3)mm below the symphysis
Copyright © 2016 ISUOG. Published by John Wiley & Sons Ltd. Ultrasound Obstet Gynecol 2017; 49: 404–408.
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Table 1 Association between recurrent prolapse symptoms and recurrent cystocele on clinical and ultrasound assessment 3 years after
laparoscopic sacrocolpopexy in 97 women
Recurrent
prolapse symptoms
Recurrent cystocele
on clinical assessment
Recurrent cystocele on
ultrasound assessment
Mesh parameter OR (95% CI) P OR (95% CI) P OR (95% CI) P
Lowest mesh position 0.99 (0.97–1.02) NS 0.94 (0.91–0.97) 0.001 0.93 (0.90–0.96) 0.001
Mesh mobility 1.00 (0.96–1.03) NS 1.05 (1.01–1.09) 0.013 1.05 (1.01–1.09) 0.012
Odds ratios (OR) are per mm of mesh position or mobility. NS, not significant.
pubis, mean apical descent was 24.2 (range, −23.2 to
56.1)mm above the symphysis pubis and mean rectocele
descent was 12.3 (range, −45.9 to 22.0)mm below the
symphysis pubis, with a negative value representing a posi-
tion below the level of the symphysis pubis. Six patients
had sonographic findings of an enterocele, with mean
measurements of 13.2 (range, −27.1 to 9)mm below the
symphysis pubis.
In patients who had concomitant paravaginal repairs,
49 had significant preoperative cystocele on clinical
examination with 45 being ≥ Stage 3, and 24 had a
significant rectocele with 15 being≥ Stage 3. At follow-up,
35 patients had recurrence in the anterior compartment
with three patients having cystocele recurrence≥ Stage 3,
and 24 had recurrence in the posterior compartment
with four cases of de-novo prolapse. Although univariate
analysis of the effect of paravaginal repairs was significant
for clinical prolapse recurrence (P=0.05), this was no
longer significant on multivariate analysis (P=0.276).
Levator avulsion was diagnosed in 39 (40%) patients
on tomographic ultrasound imaging; 18 were unilateral
and 21 were bilateral. The mean levator hiatal area on
Valsalva was 32.41 cm2.
In 37 patients, the mesh was not visible on ultrasound.
This was likely because the mesh was located too cranial
for visualization. Analysis of these patients showed that
30% (11/37) were symptomatic of prolapse and 84%
(31/37) had significant prolapse on POP-Q assessment:
21 in the anterior compartment, 17 in the posterior
compartment and none in the apical compartment.
On ultrasound, 76% (28/37) of these patients had
significant prolapse, 21 in the anterior compartment,
16 in the posterior compartment and three in the
apical compartment. Of those patients in whom mesh
could be visualized on ultrasound, 33% (20/60) were
symptomatic of prolapse at follow-up and 88% (53/60)
had recurrent prolapse on POP-Q assessment: 39 in the
anterior compartment, 30 in the posterior compartment
and none in the apical compartment. On ultrasound, 75%
(45/60) of these women had recurrent prolapse, with 29
in the anterior, 33 in the posterior and seven in the apical
compartment.
In women in whom mesh was identified in the
anterior compartment, the mesh was located, on average,
24± 11mm dorsoventral and 38± 11mm craniocaudal
from the symphysis pubis at rest. The respective figures on
Valsalva were 35± 12mm and 24± 17mm. On average,
the mesh descended 20± 11mm on Valsalva. The mean
lowermost point of the mesh was located 26±13mm
from the bladder neck at rest and 48± 25mm from the
bladder neck on Valsalva.
On univariate analysis, the lowest mesh position on
Valsalva and mesh mobility on Valsalva were both
significantly associated with recurrent cystocele on clinical
as well as on ultrasound assessment (Table 1). Odds ratios
were significant when correlating the risks of clinical
and sonographic prolapse recurrence in the anterior
compartment with the most distal position of the mesh
as well as with mesh mobility. That is, for every mm
the mesh was located further from the bladder neck on
Valsalva, the likelihood of cystocele recurrence increased
by 6–7%.
DISCUSSION
At an average of 3 years after laparoscopic sacro-
colpopexy, we have demonstrated an unexpectedly high
prevalence of recurrent prolapse in the anterior and
posterior compartments. Sacrocolpopexy mesh can be
visualized with ultrasound and appears highly echogenic
in all three orthogonal views. In this study, we were able
to visualize the mesh in 62% of patients and it was evident
that the more distal the mesh was placed in the anterior
compartment, that is the closer the mesh was placed to the
bladder neck, the less likely it was for prolapse to recur
in the anterior compartment. Our data suggested that for
every mm that the mesh is placed closer to the bladder
neck, the risk of prolapse recurrence in the anterior com-
partment on clinical examination was reduced by 6% and
on ultrasound by 7%.
The use of transperineal ultrasound has made it much
easier to assess mesh material in the pelvis as it often
appears highly echogenic. To date, there is only one
other study that has assessed abdominally placed mesh15,
and this methodology to assess sacrocolpopexy mesh has
been shown to be feasible. This is particularly relevant
given the ease of access to ultrasound machines in
most institutions and with the increasing re-uptake of
abdominally placed mesh. This appears advantageous
especially when monitoring outcomes of patients who
have undergone such a procedure.
It is interesting to note that, in this study, despite
a well-supported apical compartment, on both clinical
and sonographic assessment, this excellent apical support
seemed to have little effect on the support of the
anterior and posterior compartments. These findings
Copyright © 2016 ISUOG. Published by John Wiley & Sons Ltd. Ultrasound Obstet Gynecol 2017; 49: 404–408.
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are not unprecedented, with up to 57% of patients
diagnosed with recurrent rectocele following laparoscopic
sacrocolpopexy in a study by Baesseler et al.16. Therefore,
although apical suspension is thought to be an important
factor in success of anterior compartment surgery17, this
study suggests that addressing and providing support to
the mid-vaginal level is just as important in maintaining
a successful anatomical outcome following prolapse
repair. Hence we feel that one should aim to place
the mesh as caudal along the anterior and posterior
vagina as possible, in the hope of reducing recurrence
at mid-vaginal level. One potential consideration may
be to infiltrate with local anesthetic and adrenaline the
vesico/rectovaginal space prior to commencement of the
laparoscopic vault dissection for sacrocolpopexy. This
might reduce intraoperative bleeding when dissecting the
bladder off the vaginal vault, thus facilitating more caudal
dissections.
We acknowledge several limitations of this study.
First, this was a retrospective study and we were able
to assess fewer than half of the patients who were
operated on despite all efforts to encourage them to
return for follow-up. The large geographical distances
that patients had to travel precluded attendance of
some at our follow-up assessments. The lower rate
of return for follow-up may have accounted for some
selection bias, which could have been improved by a
prospective study design. Furthermore, in this study, we
were not able to include validated questionnaire data
to evaluate objectively functional impact and quality of
life as patients did not have preoperative questionnaires
for comparison. Again, this could be included when
conducting a prospective study.
Second, patients included in this study were from a
cohort of patients who were operated on by a single
surgeon. The outcome may be operator-dependent.
However, we would argue that this was an endoscopic
surgeon who had performed more than 50 laparoscopic
sacrocolpopexies prior to the study duration, using a
consistent technique. This meant that there was little
variance in surgical skills and our assessment is a true
reflection of the procedural efficacy.
Unlike the study of Eisenberg et al.14, we did not assess
the posterior compartment mesh as this was significantly
limited by the presence of echogenic stool bolus often
found in the rectal ampulla. Furthermore, our aim was to
assess the mesh mobility and location in relation to the
anterior compartment, and hence assessing the posterior
compartment was not our study focus. That being said,
future attention should be placed on assessing outcomes
of the mesh in the posterior compartment and the effects
of different mesh anchorage techniques.
In conclusion, using 4D ultrasound for evaluation of
mesh mobility and location following laparoscopic sacro-
colpopexy has given us a perspective on where placement
of mesh may result in failure. We found a correlation
between mesh location and prolapse recurrence, particu-
larly for the anterior compartment. Despite a higher rate
of prolapse recurrence in the anterior and posterior com-
partments, we found excellent apical suspension outcomes
with neither clinical apical recurrence nor requirement
for reoperation in 97 patients over an average of 3 years.
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Chapter 7:  A pilot study on surgical reduction of the 
levator hiatus with a mesh sling – the Puborectalis Sling 
Publication 5 
Wong V, Shek KL, Korda A, Benness C, Pardey J, Dietz HP. A pilot 
sutdy on surgical reduction of the levator hiatus – the Puborectals 
Sling, in process of submission to International Urogynaecology 
Journal.  
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7.1 Results summary 
This was a prospective study to evaluate a novel surgical procedure designed to 
reduce the levator hiatal area. In this prospective multicentre surgical trial of 115 
women, the novel surgical technique of placing a mesh sling in the infralevator space, 
lateral to and around the puborectalis muscle (the ‘puborectalis sling’) resulted in a 
significant reduction of levator hiatal area by 12cm2, which was sustained over more 
than two years (p<0.0001). Despite this however, there was 30% (28/93) 
symptomatic prolapse recurrence, 66% (61/93) clinical prolapse recurrence and 49% 
(46/93) sonographic prolapse recurrence at a mean follow-up of 2.5yrs in this high- 
risk group of women with highly abnormal pelvic floor anatomy. 
Three patients required a return to theatre with no long-term sequelae: one required 
implant removal due to infection, two had an examination under anaesthesia for 
obstructed defecation. One had a loosening of the mesh sling by division of 
anchoring sutures, the other did not require mesh adjustment.  There were no long-
term sequelae from the use of the mesh sling which appears to be a safe procedure.  
This study showed ‘proof of concept’ of a novel surgical procedure designed to 
reduce  hiatal distensibility. The procedure is successful in achieving hiatal 
area reduction with a favourable medium-term safety profile; however, 
prolapse recurrence rates were still high. A randomised controlled trial is currently 
underway to evaluate the effect of this procedure on prolapse recurrence.   
Hypothesis 5: ‘Surgical placement of a mesh sling around the puborectalis 
muscle is safe and effective in reducing hiatal area’ was confirmed. 
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7.2 Abstract 
Introduction and Hypothesis: 
Female pelvic organ prolapse recurrence has been shown to be associated with levator 
hiatal distensibility. Reducing hiatal size surgically may reduce recurrence risk. This study 
aims to demonstrate a novel surgical procedure, the puborectalis sling (PR Sling) designed 
to reduce levator hiatal area, and to assess medium-term safety and efficacy of this 
procedure.  
Methods: 
115 women undergoing prolapse repair with a pre-oSHUDWLYH KLDWDO DUHD oQ 9DOVDOYD oI  
35cm2, were recruited into this Phase 1 prospective multicentre pilot study. All underwent a 
PR Sling after completion of standard repairs.  They were followed up for 24 months. Primary 
outcome was levator hiatal area measured on ultrasound.  
Results: 
110 patients were evaluated at least 3 months post-operatively.  Mean pre-operative hiatal 
area was 43.9 (35 – 63) cm2. At 2.5 years, there was an average of 12cm2 reduction in hiatal 
area. 30% (28/93) were symptomatic of prolapse, 66% (61/93) had clinical prolapse 
recurrence whilst 49% (46/93) had sonographic recurrence. Three patients required a return 
to theatre; one case of infection resulted in mesh removal, one had obstructed 
defecation requiring sling OooVHQLQJ and another had buttock pain with faecal impaction 
that resolved after manual disimpaction. There were no long-term sequelae.  
Conclusions: 
Levator hiatal area can be reduced surgically, with almost 30% reduction in area seen in this 
pilot study. The reduction was significant and sustained up to 2 years with no major long-
term complications.  
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BRIEF SUMMARY  
Reduction of the levator hiatus is achievable in women at high risk of prolapse 
recurrence using a novel surgical technique, called the Puborectalis Sling.  
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7.3 Introduction 
Pelvic organ prolapse (POP) is a common condition with reported prevalence rates 
ranging from 2 to 48%1. The condition accounts for a lifetime risk of 10-20% requiring 
surgery2, 3. There is a high recurrence rate following repair, with almost 1 in 3 women 
requiring further prolapse surgery4. The high rates of failure have led to the 
development of vaginal mesh kits. Whilst mesh reinforcements have been shown to 
reduce recurrence5, their use is not innocuous. Mesh complications such as chronic 
pelvic pain, dyspareunia, mesh infection and erosion may occur 6.  
To address the issue of prolapse recurrence, it is important to understand and modify 
risk factors. There is a growing body of evidence identifying excessive distensibility of 
the levator ani muscle and levator avulsion as important risk factors for prolapse 
recurrence7-11. The latter is a form of birth trauma sustained by 10-30% of women 
following their first vaginal delivery12, 13. These injuries most likely occur at the time of 
foetal head crowning14, 15 and markedly increase the risk of POP, especially anterior 
and apical prolapse14, 15. Apart from macroscopic muscle tears, the degree of muscle 
stretching/lengthening during vaginal delivery may also cause permanent over-
distension of the levator hiatus. In an observational study, up to 28% of primiparous 
women sustained enlargement of the hiatal area by more than 20% during 
postpartum assessment16. A follow up study suggested that childbirth-related 
changes to levator distensibility may not regress with time17. An enlarged levator 
hiatus implies greater load on any structure supporting the pelvic organs, whether the 
supportive structure is native tissue, suture or mesh. This may explain the 
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association between an enlarged hiatal area and increased incidence of prolapse 
recurrence.  
 
In the US, a surgical procedure involving the placement of a mesh sling in the 
ischiorectal fossa, from one obturator foramen to the anococcygeal raphe and back 
to the contralateral side has been trialled in patients with faecal incontinence18. In this 
study by Rosenblatt, there were no significant procedure-related adverse events in a 
series of 29 women. Our PR sling procedure differs in that the mesh sling is secured 
onto the pubic rami and that the aim is to reduce hiatal area, which may result in 
reduction of prolapse recurrence.  
 
In this study, we intended to demonstrate proof of concept by using a mesh as a 
brace around the levator hiatus to permanently reduce the distensibility of the levator 
ani, as well as to assess the long-term safety and efficacy of this novel surgical 
procedure. The study served as preparation for an ongoing randomised controlled 
trial designed to ascertain the effect of this procedure on prolapse recurrence. 
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7.4 Materials and methods 
 
One hundred and fifteen patients were enrolled in this surgical pilot study conducted 
at two tertiary centres in 2010 - 2012. The primary inclusion criteria were a) patient 
requiring surgery for symptomatic pelvic organ prolapse and b) an enlarged hiatal 
area on VDOVDOYD oI  FP2. The latter criterion was selected in order to limit this 
phase I clinical trial to patients at high risk of prolapse recurrence. Patients with overt 
neuromuscular abnormalities, who had not completed their family and who were 
unable to provide informed consent were excluded. Primary outcome was hiatal area 
measurement on transperineal ultrasound; secondary outcomes were subjective and 
objective findings of pelvic organ prolapse recurrence.  
 
Written consent was obtained from all patients. The operation was performed under 
general anaesthesia with full muscle relaxation. The PR sling was inserted after 
completion of the prolapse repair. For PR Sling placement, a groin incision was made 
at the level of the clitoris on both sides as for placement of a transobturator sling. 
Vertical perianal incisions of 2 cm in length, 3cms lateral and 3cms inferior to the 
anus, were made bilaterally. A tunnel was created digitally just below the 
anococcygeal raphe, connecting the two perianal incisions. A 3cm x 20cm strip of 
type 1 polypropylene mesh (Johnson & Johnson/Ethicon, Somerville NJ), was 
passed through this tunnel with the help of an angled clamp. A curved Stamey needle 
(90 degree curvature) was inserted through the obturator foramen via the groin 
incision, traversing the ischio-rectal fossa to exit in the ipsilateral perianal incision to 
retrieve one end of the mesh sling. Needle insertion was performed under digital 
guidance (vaginal and rectal) to ensure that the mesh sling was placed as medially 
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as possible, along the course of puborectalis muscle, without perforating or tethering 
vagina or rectum, see Figure 1.  
Fig. 1: Puborectalis sling procedure. A shows the incisions, B insertion of the implant, 
C its retrieval by curved needle, and D anchoring of the implant to the inferior pubic 
ramus. 
The sling was tightened to obtain a genital hiatus and perineal body (Gh+Pb) 
measurement of approximately 7cm which is regarded as the limit of normal19, see 
Figure 2.  
Fig 2: Puborectalis sling procedure. Image from left to right depicts measurement of 
Gh & Pb, insertion of the sling through the post-anal tunnel, retrieval of the mesh with 
the Stamey needle, securing the mesh onto the periosteum of pubic rami and the 
final measurement of Gh & Pb reduction at the conclusion of the surgery. 
110 
The mesh sling was then secured to the periosteum of the inferior pubic rami on both 
sides, using delayed absorbable sutures. All patients were given intra-operative 
antibiotics (Cefoxitin and Metronidazole). After the first few cases we used 
preoperative bowel preparation to facilitate postoperative defecation. 
As part of the research protocol, post-operative follow-up visits were scheduled at 3, 
6, 12 and 24 months with a standardised interview, POPQ clinical assessment and 
4D transperineal ultrasound. The latter was performed in the supine position after 
bladder emptying using either GE Voluson 730 Expert or E8 systems (GE Medical 
Kretz Ultrasound, Zipf, Austria) with 8-4 MHz curved array volume transducer. The 
acquisition angle was set at 85° as previously described20.  Pelvic organ descent 
and hiatal area were measured using volumes acquired at maximum 9alsalva, 
according to published methodology21.   Hiatal area on Valsalva was measured 
using rendered volume, where the region of interest was set at 1-2cm thickness 
at the plane of minimal hiatal dimension22. All ultrasound images were analysed 
using proprietary software (4D View v.10) at a later date, with the assessor blinded 
to all clinical data.  
Subjective prolapse recurrence was defined as feeling or seeing a vaginal lump/bulge 
and/ or a dragging sensation. Clinical prolapse recurrence was defined as POPQ 
Stage 2 or higher in anterior / posterior and ≥ stage 1 in the central compartment. 
Sonographic recurrence was defined as either 1) a maximum bladder descent of  
10 mm below the symphysis pubis, 2) the uterus atWKH level of WKHsymphysis pubis 
or 3) the rectal ampulla descent of  PP EHOoZ WKH VyPSKyVLV SuELV.  
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Levator integrity was assessed using tomographic ultrasound imaging, employing a 
previously described methodology23. Levator avulsion was diagnosed if the muscle 
was disconnected from the sidewall at the plane of minimal hiatal dimension and two 
other slices at 2.5 mm interslice interval cranial to this plane. In doubtful cases, 
the levator-urethra gap measurement was used24.  
This study was approved by the local Human Research Ethics Committee (NBMLHD 
HREC 10-03). Power calculations were not performed due to the pilot nature of this 
study, with no input data available in the literature. Statistical analysis was performed 
using Minitab version 13 (Minitab Inc., State College, PA, USA). Student’s t-test was 
performed for continuous variables and chi2 analysis for categorical variables. A p-
value of <0.05 was considered to be statistically significant. 
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7.5 Results 
Among the 115 patients recruited and operated on, 113 (98%) returned for at least 
one postoperative assessment with a mean follow-up interval of 2.53 (1.72 – 5.98) 
years. Demographic and pre-operative clinical and sonographic findings are 
presented in Table 1. 
Patient Characteristics Values 
Age (years), mean (range) 60 (29 – 88) years 
BMI, mean (range) 29 (17 – 44) kg/m2 
Vaginal parity, mean (range) 
Previous operative delivery 
3 (0 – 10) 
27/115 (23%) 
Previous surgery 
Hysterectomy (%) 
Incontinence/Prolapse surgery (%) 
52/115 (45%) 
38/115 (33%) 
Pre-operative diagnosis of significant POP: 
Anterior compartment (%) 
Apical compartment (%) 
Posterior compartment (%) 
101/115 (88%) 
95/115 (83%) 
78/115 (68%) 
Pre-operative imaging 
Hiatal area on Valsalva (mean, range) 
Levator avulsion (%) 
Unilateral, n 
Bilateral, n 
43.5 (35- 63) cm2 
73/115 (63%)  
44 
29 
Table 1: Demographic and clinical characteristics of the patient population. 
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All patients were symptomatic of prolapse and all patients had prolapse of ≥ stage 2 
LQ DW OHDVW oQH FoPSDUWPHQW 7KHUH ZHUH  SDWLHQWV ZLWK  VWDJH  DQWHULoU 
compartment descent, 83  VWDJH  DSLFDO FoPSDUWPHQW GHVFHQW DQG   VWDJH  
posterior compartment prolapse. Stress urinary incontinence was reported in 68 
(59%), urge incontinence in 82 (71%), voiding difficulties in 52 (45%), obstructed 
defecation 40 (35%) and anal incontinence in 19 (17%). Preoperatively, mean 
bladder descent was 25mm (range - 65 to 66) below symphysis pubis, mean 
uterine/vault descent was 24mm (range - 60 to 30) below symphysis pubis, 
enterocele was 28mm (range - 54 to 40) below symphysis pubis and rectal ampulla 
was 21mm (range -45 to 18) below symphysis pubis. Mean hiatal area on Valsalva 
was 43.5 (range 35 – 63) cm2 DQG   KDG VHYHUH KLDWDO EDOOooQLQJ  
40cm2). Levator avulsion was diagnosed in 73 (63%).  
A vaginal hysterectomy was performed in 47 women, a vault suspension in 66, an 
anterior repair in 95, a posterior repair in 80. A transobturator anchored mesh was 
inserted in 37, and a mid-urethral sling in 38. There were no cases of vaginal or 
rectal/anal perforations or major intraoperative complications with the puborectalis 
sling insertions. There was one case of rectal perforation during a concomitant Miya 
hook sacrospinous colpopexy. The suture was removed immediately with no adverse 
sequelae. There was one case of inadvertent cystotomy during vault dissection for 
sacrospinous fixation, which was recognised in theatre and repaired without any 
long-term consequences. There were 2 cases of infra-pubic needle passage during 
PR sling placement and several cases of mesh dislodgements from the needle on 
mesh retrieval, necessitating repeated Stamey/Pereyra needle passes. The 
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maximum number of needle passes on one side was 3. No procedure had to be 
abandoned for any reason. 
In the postoperative period, one patient required removal of the PR Sling on Day 
10 due to infection. Another woman had periosteal sutures cut ELODWHUDOOy on Day 9 
due to worsened obstructive defecation. One additional woman had an examination 
under anaesthesia for severe buttock pain on Day 10. She was found to have 
significant faecal impaction that was addressed in theatre without requiring sling 
adjustment. She had a fleet enema DV ZHOO with good effect and resolution of pain.   
There were no cases of puborectalis sling erosion. There were several cases of 
mesh erosions into the vagina during the follow-up period, all related to Perigee mesh 
VHH WDEOH  $OO UHVoOYHG ZLWK FoQVHUYDWLYH FDUH H[FHSW WZo ZLWK DQ HUoVLoQ oI  
5mm, who underwent mesh trimming in clinic at 12 months post-operative follow-up.  
Five patients required further procedures for symptomatic prolapse during the follow-
up period: one had a Perigee insertion with bilateral sacrospinous fixation, two had 
revision of Perigee and posterior repair with bilateral sacrospinous fixation, one had a 
posterior repair with bilateral sacrospinous fixation and the fifth patient had a Perigee 
with posterior repair and a repeat Puborectalis sling insertion eighteen months 
following her initial surgery. One patient required a transobturator sling for USI at 12 
months’ following surgery and another patient underwent a Delorme’s procedure for 
rectal prolapse six months after the index surgery.  
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Subjective and objective outcomes at each follow-up time point are shown in Table 2. 
Table 3 showed a breakdown of significant clinical prolapse recurrence in individual 
compartment at follow-up. Urinary and bowel function outcomes over each follow-up 
time points DUH shown in Table 4. The reduction in hiatal area, as compared to pre- 
operative measurements, was highly significant at all follow-up time points and was 
maintained throughout the two-year follow-up period (Table 2).  
Parameter 
Pre- op. 
status 
(n=115) 
3 m postop 
N= 110 
6 m postop 
N=106 
12 m postop 
N=92 
24 m postop 
N=93 
Subjective satisfaction - 95/110 (86%) 88/106 (83%) 77/92 (84%) 73/93(78%) 
Subj. improved/ cured - 99/110 (90%) 98/106 (92%) 82/92 (89%) 81/93(87%) 
Prolapse symptoms 115 18/110 (16%) 24/106 (23%) 22/92 (24%) 28/93(30%) 
Clinical recurrence in 
any compartment 
- 80/110 (73%) 77/106 (73%) 71/92 (77%) 61/93(66%) 
Significant prolapse on 
Ultrasound* 113 50/110 (45%) 54/106 (51%) 52/92 (57%) 46/93(49%) 
Hiatal area on 
Valsalva,  
mean (cm2, SD) 
43.5 (6.5) 30.5 (6.2)** 31.0 (6.9)** 32.1 (7.6)** 31.8 (7.5)** 
Table 2: Subjective and objective outcomes after prolapse repair with puborectalis 
sling at 3, 6, 12 and 24 months. *Cystocele ≥10mm below symphysis pubis (SP), 
uterus 15mm above SP, rectal ampulla ≥15mm below SP ; **Reductions in hiatal 
area all p< 0.001 at 3,6, 12 and 24 months. 
Table 3: POPQ assessment preoperation and at 3, 6, 12 and 24 months post-operation. 
Follow-up 
time points 
,&632346WDJH
2 
Anterior 
,&632346WDJH 
Posterior  
ICS POPQ 
Stage 1 
Apical 
Pre-operatively 101/115 (88%) 78/115 (68%) 95/115 (83%) 
3 months post-operative 
Mean POPQ (range) 
60/110 (55%) 
Ba -1 (-3 to 5) 
32/110 (29%) 
Bp -2 (-3 to 2) 
20/110 (18%) 
C -6 (-10 to 6) 
6 months post-operative 
Mean POPQ (range) 
57/106 (54%) 
Ba -1 (-3 to 5) 
29/106 (27%) 
Bp -2 (-3 to 2) 
22/106 (21%) 
C -5 (-9 to 6) 
12 months post-operative 
Mean POPQ (range) 
58/92 (63%) 
Ba -1 (-3 to 5) 
37/92 (40%) 
Bp -2 (-3 to 3) 
25/92 (27%) 
C -5 (-9 to 7) 
24 months post-operative 
Mean POPQ (range) 
45/93 (48%) 
Ba -1 (-3 to 5) 
33/93 (35%) 
Bp -2 (-3 to 5) 
22/93 (24%) 
C -5 (-8 to 5) 
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Table 4: Symptomatic outcome of urinary and bowel function at each follow-up time 
points. All mesh erosions were secondary to PerigeeTM mesh.  
Parameters 
Pre-
operative 
(n=115) 
3 months 
post- 
operative 
(n=110) 
6 months 
post- 
operative 
(n=106) 
12 months 
post-
operative 
(n=92) 
24 months 
post-
operative 
(n=93) 
Urinary incontinence 
Stress 
Urge 
68 
82 
21 
41 
19 
31 
16 
31 
30 
49 
Voiding difficulty 52 19 27 35 29 
Mesh erosion - 4 3 3 2 
Obstructed 
defecation 
40 23 18 21 28 
Faecal incontinence 
(FI) 
19 12 10 10 11 
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7.6 Discussion 
 
In this pilot study investigating a novel surgical procedure, we have shown that 
levator hiatal area can be successfully reduced with a mesh sling, the Puborectalis 
Sling, providing proof of concept. A significant reduction in levator hiatal area was 
seen in one hundred and ten patients with an 81% follow-up rate at the two-year 
mark. On average, the levator hiatal area was reduced by 12cm2, which equates to a 
reduction of almost 30%. The effect was sustained up to 2 years post-operatively with 
no major long-term complications related to the puborectalis sling.  
 
Despite an anatomical recurrence of 66% at 24 months post-operative, only 30% 
were symptomatic of prolapse and <10% required re-operation for their prolapse. The 
high rate of objective prolapse recurrence is likely due to strict definitions (POPQ 
stage 2 anterior and posterior compartment, stage 1 central compartment) and the 
fact that we performed this study exclusively in patients at high risk of recurrence, 
resulting in an average pre-operative hiatal area of over 43cm2 and a very high 
avulsion rate of 63% in this cohort. 
 
The insertion of the puborectalis sling at the completion of prolapse surgery is a novel 
surgical approach based on a perception of pelvic organ prolapse as a hernia 
through the levator hiatus. Since this hernia portal cannot be obliterated (like in the 
case of umbilical hernia), or nearly obliterated (as in the case of femoral or inguinal 
hernia), the only option is to reduce its size permanently. While this has been 
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attempted by the abdominal route, this approach is highly morbid and was 
abandoned decades ago25.  
The Puborectalis sling is based on the TOPAS posterior anal sling26, but it uses a 
wider mesh and requires anchoring to the periosteum of the inferior pubic rami. 
Although tunnelling post-anally towards the anococcygeal raphe may prove to be 
unfamiliar to gynaecologists/urogynaecologists, there were no reported intra-
operative complications directly related to the anchoring and placement of the 
puborectalis sling. Hence the method seems to be technically feasible and accessible 
to any competent gynaecological surgeon. 
There were three cases that required return to the operating theatre during the study 
period. One was in a patient with Type 2 diabetes and chronic pelvic pain. She 
developed persistent pain and progressive erythema at the peri-anal incision sites, 
unresponsive to antibiotics. Removal of her puborectalis sling on Day 10 involved re-
opening of the transobturator incision sites bilaterally, dividing of the anchoring 
sutures and removal of the sling in total via one of the peri-anal incisions.  
The second patient required a return to the operating theatre due to faecal impaction 
on Day 9. Her puborectalis sling was released by re-opening the groin incisions, 
cutting anchoring sutures bilateral and applying downward vaginal/anal traction to 
loosen the sling. Her symptoms resolved immediately after sling release. The third 
patient who also suffered from faecal impaction had an examination under 
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anaesthesia only with conservative treatment. All patients recovered well with no 
long-term sequelae.  
There are several limitations of this study that need to be addressed. Firstly, we did 
not acquire validated questionnaires pre-operatively, therefore evaluation of 
subjective outcomes was dependent on the physician-directed interview. Although 
this may not evaluate subjective outcome comprehensively, this question was asked 
in an identical fashion before and after the procedure and has been found sensitive 
to prolapse recurrence27. At any rate, our primary aim was to evaluate anatomical 
changes following insertion of the PR Sling and not subjective outcomes.  
Secondly, this was a study that was performed at two tertiary centres involving two 
urogynaecology subspecialist surgeons, subspecialty fellows and specialist trainees. 
It is possible that heterogeneity of surgical practice may have affected outcomes. 
However, we believe that our results are reflective of standard subspecialty practice 
at a public hospital, where different surgeons of varied skills are involved in 
patients’ care and surgery. As a result, we feel that our results may be more 
generaliVable.  
The association between levator hiatal area enlargement, pelvic organ prolapse and 
recurrence has been comprehensively demonstrated 10, 11. Thus, the ability to reduce 
levator hiatal area as shown in this pilot study is potentially an important step forward 
in optimising prolapse surgery outcomes.  In this study, the majority of our patients 
had severely compromised pelvic floor muscle support. Therefore, any surgical 
attempt to treat prolapse in this cohort would be challenging. After proving the 
feasibility of hiatal reduction with an acceptable short and medium term safety profile, 
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we are now performing a randomised controlled trial evaluating the puborectalis sling 
as an adjunct to conventional prolapse surgery. Recruitment is nearly complete at the 
time of writing. However, it is already evident that biomechanical properties of 
implants play a larger role than expected, and we are continuing the search for 
optimal materials to be used in hiatal reduction surgery. 
In conclusion, this observational trial of a novel surgical procedure has shown that 
the levator hiatus can be reduced safely and efficiently with a ‘puborectalis sling’. The 
resulting reduction in hiatal area on Valsalva is sustained to at least 2.5 years after 
the procedure. 
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INTRODUCTION
Einstein once said, ‘In the middle of difficulty, lies opportunity’. 
However, in this current climate when the use of synthetic trans-
vaginal mesh in pelvic organ prolapse (POP) surgery is associated 
with increasing negative publicity, there is limited opportunity for 
progress in this field. In fact the authors consider what happened 
over the last few years a retrograde development. The blanket 
decision to suspend all mesh use in pelvic floor reconstructive 
surgery in Scotland in 2014, including synthetic suburethral slings 
which have a proven success record reaching back about 20 years, 
is an obvious example. The recent removal from the market of 
transobturator meshes including the Perigee™ (American Medical 
Systems (AMS), Minnetonka, MN, USA) and Anterior Prolift™ 
(Ethicon, Somerville, NJ, USA) is another example of a retrograde 
development. While these were largely commercial decisions, it 
is inevitable that clinicians are now forced to revert back to pro-
cedures that have been shown to be less effective. In our opin-
ion the discussion surrounding the use of transvaginal mesh has 
been dominated by emotion rather than science.
Surgical management of POP is a challenging condition for pel-
vic reconstructive surgeons, with approximately one- third of pro-
lapse procedures performed for recurrence.1 Among the different 
forms of POP, cystocele can be a particularly difficult condition to 
manage with a recurrence rate after traditional repair between 
40 and 63%2–5 and up to 90% in some women.6 For this reason 
clinicians dealing with POP have been in a constant search for 
surgical techniques to improve outcomes. Mesh has been used 
in pelvic floor repair dating back to 1955, when Moore et al.7 first 
used tantalum mesh for anterior compartment prolapse repair. 
However, transvaginal mesh implants did not become popular 
until after the worldwide success of midurethral slings introduced 
in the early 1990s, triggering the development of anterior vaginal 
meshes anchored via the transobturator route (Anterior Prolift™ 
Ethicon, Somerville, NJ, USA and Perigee™ AMS, Minetonka, MN, 
USA) in 2003–2004. Anterior anchored mesh kits were intended to 
provide better load resistance than native tissues in a minimally 
invasive approach, aiming to improve anatomical success rates. 
The introduction of these kits was followed by rapid and wide-
spread adoption of polypropylene mesh in spite of limited data 
on safety and efficacy. In the USA, the use of vaginal mesh for 
prolapse repair increased from 8.1% in 2005 to 22.8% in 2010.8
Over the last decade, a growing body of data in this field 
has improved our understanding of mesh efficacy and safety. 
Accumulated evidence now suggests that synthetic mesh aug-
mentation is superior to traditional repair for anterior compart-
ment prolapse.9,10 In a recent systemic review11 including 13 
randomised controlled trials (RCTs) and seven cohort studies, the 
use of synthetic nonabsorbable anterior compartment mesh was 
shown to result in superior anatomical success and relief of sub-
jective prolapse symptoms, as well as lower re- operation rates for 
prolapse compared to native tissue repair. However, transvaginal 
mesh was not found to improve success in posterior and apical 
prolapse repair.
The marked rise in vaginal mesh procedures has seen a dra-
matic increase in mesh- related complications. Some of these are 
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serious and novel.12 Complications such as mesh erosion, pelvic 
pain, dyspareunia and bowel or urinary tract injuries can be chal-
lenging to manage.10,13 This has led to a growing concern regard-
ing mesh use and an onslaught of negative media publicity along 
with litigation. In a systematic review,11 mesh erosion rates were 
found to range from 1.4 to 19% at the anterior vaginal wall and 
reoperation rates were 3–8%. In another review no differences 
in the rates of de novo dyspareunia were found between ante-
rior colporrhaphy and anterior mesh.10 In regard to chronic pel-
vic pain following mesh use, some authors have suggested that 
mesh shrinkage is a contributory factor;14 however, to date, the 
majority of studies on mesh shrinkage, retraction or contraction 
were performed with an assessment at a single time point.15,16 
Studies that evaluated mesh characteristics in vivo over multiple 
time- points have shown that mesh shrinkage was limited to the 
phase of physiological scar formation, that is, the first three post- 
operative months. These studies suggest that the greatest reduc-
tion in mesh size is likely due to a folding effect related to surgical 
technique or mesh design.17,18
We should not forget the basic fact that any surgical procedure 
carries risks. This is also true for prolapse surgery, whether with 
or without mesh. The decision for or against surgery requires a 
balancing of risks and benefits in the individual case. There is no 
doubt that serious mesh complications do occur and that such 
can be a major problem for women and clinicians alike. However, 
we hold that in some women at high risk of POP recurrence after 
conventional surgery, a rational assessment of the balance of 
risks and benefits will favour the use of mesh. The probability of 
recurrence after cystocele repair seems to vary enormously from 
one person to the other, from 10 to 90%.6 Hence, the balance be-
tween risks and benefits of transvaginal mesh repair versus con-
ventional surgery will differ from patient to patient. It is prudent 
therefore to assess individual recurrence risk whenever mesh im-
plantation is contemplated.
A number of risk factors for prolapse recurrence have been 
identified in the literature, including younger age,19,20 advanced 
stage of prolapse,19–22 family history of prolapse,21 previous pro-
lapse surgery, a larger genital hiatus, poor pelvic floor muscle 
contractility,23 higher body mass index19 and previous sacrospi-
nous fixation.21 More recently, levator avulsion3,21,24,25 and hiatal 
ballooning,6 that is, an abnormally distensible levator hiatus, were 
found to be important risk factors for POP recurrence. Levator 
avulsion is a form of maternal birth injury where the most ventro-
medial aspect of the levator ani muscle is detached from the infe-
rior ramus of the os pubis. It is associated with hiatal ballooning, 
reduced pelvic floor muscle contractility and increased muscle 
distensibility.26 These mechanisms may underlie the association 
between levator avulsion and POP recurrence. Studies on recur-
rence risk have shown an odds ratio (OR) ranging 2- 3 in women 
with avulsion.3,21,24,25,27 The impact of major levator defects has 
also been demonstrated on magnetic resonance imaging. In a se-
ries of 83 women, Morgan et al.28 reported poorer anterior vagi-
nal support in patients with major levator defects six weeks after 
primary surgery for prolapse. In an ultrasound study comprising 
334 women assessed at a mean of 2.5 years after cystocele repair, 
levator avulsion was associated with an OR of 2.95 for recurrence, 
and hiatal area on Valsalva conveyed an additional 7% per cm2 
for recurrent risk. The likelihood of recurrence may vary from 
10 to 90% in a patient with a given degree of cystocele, depend-
ing on the pelvic floor status, that is, integrity of the levator ani 
muscle and hiatal area on Valsalva.6 Both factors in combination 
may effectively identify patients in whom conventional surgery 
is likely to fail, and this effect seems to explain most other de-
scribed predictors of recurrence, such as younger age, enlarged 
genital hiatus and poor levator contractility. It has become evident 
that pelvic floor assessment should be part of the assessment in 
women with POP.
In the modelling study by Rodrigo et al., the authors showed 
that anterior anchored mesh can partially compensate the effect 
of levator avulsion and significantly reduce the risk of POP recur-
rence in women with avulsion. A woman with avulsion and a hiatal 
area of 40 cm2 on Valsalva was estimated to have a recurrence 
risk of around 80% with traditional surgery and 45% with anterior 
mesh repair.6 Testing this claim in a randomised controlled trial, 
Svabik et al.29 compared native tissue repair to mesh kit surgery 
for vaginal vault prolapse in patients with levator avulsion. The 
authors showed significantly less prolapse recurrence in the latter 
group. In this study of 72 patients, 3% had anatomical recurrence 
at one year after Prolift Total™ (Gynecare, Ethicon, Sommerville, NJ, 
USA) compared to 65% after sacrospinous fixation. Abdominally 
placed mesh, an alternative surgical option to transvaginal mesh 
in this situation, is rather unlikely to show comparable surgical 
outcomes. A study of almost 100 women after laparoscopic sac-
rocolpopexy by an experienced laparoscopic surgeon showed 
anterior compartment recurrence in 62% of the study population 
at a mean follow- up of three years.30 The study highlighted the 
need to extend abdominal mesh implants as caudally as possi-
ble in order to provide adequate support to the mid- vaginal level. 
However, this may be challenging, even in the hands of experi-
enced surgeons because of intraoperative bleeding during deep 
anterior dissection under the trigone.
Unfortunately, most mesh kit products entered the market 
with little information on safety and efficacy. Since then we have 
become much better at understanding risks and benefits: there 
now is ample evidence supporting mesh use in certain women 
with increased risk of prolapse recurrence. Regrettably, it appears 
that this knowledge is coming too late. We are witnessing the de-
mise of mesh kits due to negative publicity as a result of indiscrim-
inate marketing, suboptimal implant design, inadequate surgical 
techniques and poor patient selection. While there are mesh kits 
still available in Australia and New Zealand, there is little data on 
long- term efficacy of these newer kits and furthermore, they dif-
fer fundamentally in that they are not anchored or insufficiently 
anchored to the pelvic sidewall as compared to the kits that have 
previously been studied. It is depressing to see the demise of a 
surgical option precisely at a time when we are finally starting to 
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understand the risks and benefits of that option in individual pa-
tients. It is equally depressing to counsel prolapse patients with 
levator avulsion and an enlarged levator hiatus who want and de-
serve surgery with the best chance of success, and to confess that 
we are unable to provide optimal surgical intervention as a result 
of regulatory and medicolegal interference.
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Chapter 9: Discussion and Conclusion 
  
Female pelvic organ prolapse is a highly prevalent condition that can significantly 
impair quality of life. Women suffering from POP are more likely to report poorer 
sexual wellbeing as well as urinary and bowel dysfunction (1). Furthermore, urinary 
and bowel symptoms including incontinence are not uncommon in women with POP 
(2, 3). With ageing populations in developed countries, the absolute number of 
patients requiring treatment for POP will increase significantly in the coming years (4). 
Therefore, it is evident that research in this area should be a high priority. Such 
research should include efforts to improve our understanding of the pathophysiology 
of POP as well as the investigation of novel surgical techniques to improve surgical 
outcomes. This thesis was designed with these aims in mind.  
 
At the outset of this work, a set of hypotheses were posited:  
 
1. Mesh augmentation for anterior compartment prolapse is associated 
with better outcome as compared to traditional anterior colporrhaphy.  
2. Levator avulsion is a risk factor for prolapse recurrence after anterior 
mesh repair. 
3. Vaginal mesh with apical anchoring to the sacrospinous ligaments are 
associated with improved outcomes compared to mesh implants with 
sidewall fixation. 
4. Abdominally placed mesh for apical or uterine prolapse is effective for 
anterior compartment support. 
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5. Surgical placement of a mesh sling around the puborectalis muscle is
safe and effective in reducing hiatal area.
Finally, I attempted to answer the question: 
6. Should mesh continue to be available for the pelvic reconstructive
surgeon?
We were able to test all hypotheses posited above, with largely conclusive 
results. The final question I attempted to answer was should mesh continue to be 
available for pelvic reconstructive surgeon?  In this opinion piece, we claimed that 
a blanket withdrawal of vaginal mesh for prolapse repair would be a disservice to 
our patients, especially those with recurrent and severe prolapse. Such 
regulatory intervention would create an even bigger dilemma for the management 
of women with abnormal pelvic floor anatomy, failed multiple vaginal native tissue 
repairs, and in those at high risk of complications with abdominal surgery. For these 
patients and especially those presenting for the first time diagnosed with levator 
avulsion, the use of transvaginal mesh may be the safest and most effective 
surgical option.  
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9.1 Conclusions:  
 
With approximately one-third of prolapse surgeries performed for recurrence (5), 
clinicians dealing with POP are in constant search for surgical techniques to improve 
outcomes.  Among the different forms of POP, cystocele is particularly challenging to 
manage and for this reason, clinicians have constantly modified repair techniques 
over the years in hope of reducing failure rates. The concept of introducing a foreign 
material to provide better organ support derived from data on abdominal hernia 
repairs (6, 7), and indeed pelvic organ prolapse is a hernia through the largest 
potential hernial portal in the human body, the levator hiatus. The efficacy of mesh 
augmentation in prolapse repair has been shown in several large randomised 
controlled trials (8, 9), even in unselected populations. In the RCT by Altman et al, 
trocar-guided mesh kits provided higher success rates using composite outcome 
assessment. In this study of 389 women, those who had mesh kit repair had less 
objective and subjective failures at 1 year after the index surgery (8). Unfortunately, 
no attempts were made to identify those patients best suited for transvaginal mesh 
augmentation.  
 
The widespread non-selective use of transvaginal mesh since 2004 has resulted in a 
dramatic increase in women presenting with mesh-related complications. 
Unfortunately, due to injudicious use of the new technology, patients who did not 
require mesh insertion, or those who were likely to gain minimal benefit, were 
exposed to these additional risks. Some of these complications were serious and 
novel (10). Concerns fuelled by mesh-affected patients and medicolegal actions have 
led to numerous clinical debates on vaginal mesh utilisation (11-15).  Concerns about 
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mesh safety and negative publicity have seen the removal of some transvaginal 
mesh products for prolapse in Australasia (16), a suspension of their use in Scotland 
(17) and the United Kingdom and numerous cases of litigation, including class action 
law suits against manufacturers in the US and Australia (18).  
Opponents of mesh use overlook the fundamental principle that any surgical 
procedure carries risks (19). These risks apply to prolapse surgery, whether with or 
without mesh use. The decision for or against a certain surgical procedure requires 
balancing of risks and benefits in the individual case. Lack of efficacy and safety data 
of transvaginal mesh and an absence of information on risk factors for recurrence 
have precluded a rational assessment of the balance of risks and benefits until 
recently. One of the aims of this work was therefore to identify patients who are more 
likely to benefit from mesh repair and to provide a better understanding of mesh 
augmentation in prolapse repair.    
Levator avulsion, which affects 10-30% of women following vaginal childbirth (20), is 
associated with weaker pelvic floor muscle support and an abnormally distensible 
hiatus (21). It is a strong risk factor for POP and is likely to be the missing link 
between childbirth and POP (22). Several studies have also identified levator 
avulsion as a risk factor for POP recurrence (23-25), as confirmed in a recent meta-
analysis (26). During the course of this thesis, a modelling study on 334 women 
following cystocele repair demonstrated that levator avulsion and hiatal area on 
Valsalva were independent risk factors for prolapse recurrence. Levator avulsion was 
shown to be associated with an odds ratio of 2.94 for sonographic cystocele 
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recurrence and for each cm2 enlargement of the hiatal area on Valsalva, the risk of 
prolapse recurrence increased by 7%. The use of anterior anchored mesh was 
associated with a reduced risk of recurrence with an OR 0.4. This risk reduction was 
limited to patients with levator avulsion (27), concurring with the findings in Chapter 3. 
The findings from this study have filled our knowledge gap in regards to patient 
selection for mesh use: clearly, avulsion may be considered an indication for mesh 
use. 
While randomised controlled studies have found a higher objective cure rate after 
transobturator mesh repair compared to anterior colporrhaphy (9, 28) in unselected 
patients; recurrent cystocele even after mesh is not uncommon (29). There is 
however limited data on risk factors for mesh failure. In the study on women with 
anterior mesh repair in Chapter 4, women diagnosed with levator avulsion were 
shown to have a higher recurrence rate, highlighting the importance of the condition 
in pelvic floor medicine. Developing measures to compensate for the effect of levator 
avulsion may be an option to reduce recurrence after surgery.  
Prolapse of the bladder or cystocele seems to be associated with apical prolapse (30) 
which has led some authors to suggest that effective apical support should lead to 
better cystocele cure rates. This line of reasoning resulted in the introduction of the 
Anterior ElevateTM mesh kit (American Medical Systems, Minnetonka, USA) in 2008. 
However, there is limited data in the literature on anatomical outcomes after Anterior 
ElevateTM, which involved tissue anchor placements into the obturator foramen and 
sacrospinous ligament, compared to mesh systems involving anchoring via mesh 
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arms placed through the obturator fossa, such as the Perigee™ (American Medical 
Systems, Minnetonka, USA). The superiority of the Perigee™ mesh kit system was 
demonstrated in Publication 3, both on clinical examination and on ultrasound 
assessment, almost one year after prolapse repair (31). This study showed that not 
all mesh kits are the same. The discrepancy in performance is likely related to 
anchoring. It is plausible that mesh fixation with transobturator mesh arms provides 
better anchoring and load-bearing ability than tissue anchors placed in the obturator 
fascia.  
Laparoscopic sacrocolpopexy, a surgical procedure for vault or uterine prolapse, has 
been shown to be highly effective in apical compartment prolapse (32). However, this 
does not necessarily translate to satisfactory anterior and posterior compartment 
support (33). This has also led to the question of whether surgical outcome, 
especially with mesh placed abdominally, depends on how distal the mesh is placed 
along the anterior vaginal wall. 
In Publication 4, a study of 100 patients after laparoscopic sacrocolpopexy performed 
by an experienced surgeon, we found the rate of anterior compartment recurrence to 
be over 60%, whilst no recurrence was noted for the apical compartment at a mean 
follow-up of three years. These findings concur with a study by Higgs et al who 
reported that failures in the anterior and posterior compartment were common after 
sacrocolpopexy (34) contradicting the notion that apical suspension is crucial to 
anterior compartment support (30). A correlation between mesh location and mobility 
with cystocele recurrence shown in Publication 4 highlights the need to extend 
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abdominal mesh implants as caudally as possible to provide adequate support to the 
mid-vagina. However, in practice this may be limited by poor visualisation and difficult 
dissection, especially close to the ureters.  
An enlarged levator hiatus is one of the strongest independent risk factors for 
prolapse recurrence (35). This is because the forces acting on pelvic support 
structures are directly proportional to size of the hiatal area (36). Therefore, it seems 
plausible that measures aiming at reducing the hiatal area may decrease prolapse 
recurrence by reducing the load on pelvic organ support.  This has led to the 
development of a novel surgical technique, the ‘Puborectalis Sling’. In an attempt to 
evaluate its safety and efficacy, a pilot study was conducted. In Publication 5, a 
multicentre surgical trial on 117 women revealed a significant reduction of levator 
hiatal area by 12cm2 that was sustained for well over two years. However, normal 
hiatal dimensions of <25 cm2 were achieved in only a minority of women. This 
may largely be due to sub-optimal biomechanical properties of the polypropylene 
mesh used for this purpose. In a study by Li et al., the authors showed that mesh 
material available in reconstructive surgery was suboptimal (37) for the purpose of 
permanent load-bearing in that the implants underwent significant ongoing 
permanent deformation (‘creep’) with elongation when placed under tension. This 
is largely due to slippage of monofilament fibres within a woven mesh. Hence, any 
hiatal reduction achieved at the time of surgery is unlikely to be sustained. Our 
unit is involved in ongoing efforts to design and use stiffer mesh that 
displays less permanent deformation.  
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9.2 Directions for future research 
The findings of this thesis have led to several research questions: 
Can reduction of hiatal area with the puborectalis sling reduce prolapse 
recurrence in women with an abnormally distensible hiatus?   
The pilot study in Publication 5 has confirmed the feasibility of a new surgical 
procedure which involved placing a mesh strip in the infralevator space of the 
ischiorectal fossa, lateral and posterior to the puborectalis muscle. The Puborectalis 
Sling procedure was shown to be safe and effective in achieving significant reduction 
of the hiatal area. Moving forward, the next step is to evaluate its effectiveness in 
reducing prolapse recurrence compared to traditional prolapse repair only in women 
with levator hiatal ballooning. The author is currently involved in an ongoing 
multicentre randomised controlled trial with this aim.  
Can concomitant levator repair during prolapse surgery improve surgical 
success? 
In a pilot study on 17 patients, Dietz et al reported disappointing results after surgical 
reattachment of the puborectalis muscle stump to the inferior pubic ramus using a 
piece of mesh (38). Five patients had prolapse recurrence beyond the hymen and the 
mean hiatal area on Valsalva was reduced from 36.84cm2 to 30.71cm2. This 
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remained above the normal cut-off value (25cm2) of hiatal area enlargement. While 
this early result was disappointing, it remains a worthwhile approach to explore 
in WKH future, perhaps with different graft/mesh material or perhaps by selecting 
patients with levator avulsion only but without major degrees of hiatal area 
enlargement. Such a project is currently ongoing. 
Can surgical outcome of laparoscopic sacrocolpopexy be improved with 
robotic surgery?  
Technical limitations in extending abdominal mesh implants as caudally as possible 
during laparoscopic sacrocolpopexy may explain high recurrence rates in the anterior 
and posterior compartments. Further work needs to be done to evaluate whether 
robotic surgery can improve surgical outcomes as a result of improved arm 
articulation and better visualisation of tissue planes. 
Is it possible to prevent levator avulsion and de novo hiatal ballooning after 
vaginal childbirth?  
Levator avulsion and hiatal ballooning are risk factors for prolapse development. 
Women with levator avulsion suffering from symptomatic POP are more likely to fail 
surgical treatment.  Whilst more work needs to be done to improve the surgical 
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treatment of POP in women with levator trauma, it is evident that preventative 
strategies should be implemented to prevent such trauma in the first place.  
Amongst antepartum and intrapartum risk factors of levator trauma such as maternal 
age, BMI, forceps, length of 2nd stage and head circumference (39-41), forceps 
remains the most obvious modifiable risk factor (20, 42, 43). Within Australia, the rate 
of forceps delivery ranges between 2 to 15% (44, 45) and the risk of avulsion 
associated with forceps delivery ranges between 30 – 65% internationally (20, 43, 44, 
46, 47). Hence, it seems reasonable to suggest that forceps delivery should be 
abandoned to prevent levator trauma that may lead to subsequent development of 
POP. Other measures that could be useful and need to be studied in the future 
include methods to condition the pelvic floor muscles for delivery e.g. intrapartum 
stretching of the pelvic floor muscle or use of muscle relaxants such as epidurals or 
pudendal nerve blocks during the second stage of labour.  
Recurrence after pelvic reconstructive surgery is a major clinical issue, leading to the 
quest to reduce recurrence, and the design of this thesis. The rapid development of 
pelvic floor medicine over the last fifteen years has seen an enthusiastic uptake of 
transvaginal mesh kits, followed by their swift demise in some jurisdictions. While 
none of the transvaginal mesh products studied in this thesis remain available in 
Australasia, this work has shown the role of mesh in selected patients and has 
highlighted the importance of proper patient selection in pelvic organ prolapse 
management. It has also highlighted the importance of ‘proof of concept’ studies in 
surgery, and the need to evaluate efficacy and safety of treatment before its 
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widespread use in clinical practice. Our pilot study on the ‘Puborectalis Sling’ is an 
example of such ‘proof of concept’ in the development of new surgical procedures. A 
randomised controlled trial, the next step in the evaluation of surgical techniques, is 
ongoing. Regardless of the outcome of this particular trial, the problem of prolapse 
recurrence after reconstructive surgery is likely to posit challenges to clinicians and 
researchers alike for many years to come. 
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